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A cardioprotective and antiarrhythmic role of magnesium pre-treatment against ischaemic injury in 
isoprenaline-induced hypertrophic rat hearts 
Matthew Amoni, Roisin Kelly-Laubscher and Asfree Gwanyanya
University of Cape Town, Rondebosch, South Africa
Introduction: The stress of cardiovascular diseases induces a pathological cardiac remodelling process that leads to hypertrophy. Cardiac hypertrophy 
is associated with myocardial dysfunction and arrhythmogenesis, as well as poor prognosis of ischaemic heart diseases. Magnesium (Mg2+) is used to 
treat several cardiovascular conditions, but its effects in pathological cardiac hypertrophy remain unclear. This study investigated the effects of Mg2+ on 
ischaemia/reperfusion (I/R) injury in isoprenaline (ISO) induced hypertrophic hearts. 
Method: Five groups of adult Wistar rats were treated daily for seven days with either ISO (1.25mg/kg subcutaneously), MgSO4 (270mg/kg 
intraperitoneally), saline or combinations thereof. Hearts perfused on a constant-pressure Langendorff system were subjected to regional I/R injury, 
except the sham group. Haemodynamic and electrogram parameters were recorded on a PowerLab data-acquisition system. Infarct size was determined 
by triphenyltetrazolium chloride staining and quantifi ed as a percentage of the area-at-risk delineated by Evans blue staining. 
Results and conclusion:  Co-treatment with Mg2+ decreased I/R-induced infarct size from 49.0 ± 8.5% to 25.1 ± 5.4% (p=0.003, n=6/group) in ISO 
treated hearts, but not in control hearts. Mg2+ also reduced episodes of I/R induced ventricular premature beats, ventricular tachycardia, ventricular 
fi brillation and the overall arrhythmia score in ISO treated hearts from 13.4 ± 2.0 to 3.2 ± 1.1 (p<0.05, n=5-7/group). Neither ISO, nor Mg2+ had 
detrimental effects on the I/R-induced changes in haemodynamic parameters, including left ventricular developed pressure and time constant of 
relaxation (tau), or the coronary fl ow rate. Mg2+ did not reverse the ISO induced increase in heart weight-to-body weight ratio. These results suggest 
that Mg2+ prophylaxis reduces I/R-induced myocardial injury and arrhythmias in hypertrophied hearts, without altering heart weight. Thus there is a 
potential role for Mg2+ in the management of pathological cardiac hypertrophy, but its benefi ts in non-diseased hearts remain unclear. 
Improvement of diabetes-induced cardiac autonomic dysfunction and left ventricular diastolic pressure-
volume response by magnesium pre-treatment in streptozotocin-induced diabetic rats
Matthew Amoni, Roisin Kelly-Laubscher and Asfree Gwanyanya
University of Cape Town, Rondebosch, South Africa
Introduction: Diabetes is a growing health problem affecting approximately 9% of the world’s population. Morbidity and mortality in diabetes are 
mainly due to cardiovascular complications, which include autonomic dysfunction and pathological cardiac remodelling. Diabetes is associated with 
electrolyte abnormalities such as hypomagnesaemia, a known cause of cardiac dysfunction and remodelling. This study investigates the effects of 
magnesium (Mg2+) treatment on diabetes-induced cardiac complications. 
Method:  Four groups of adult Wistar rats were each treated with a single dose of, either streptozotocin (50mg/kg intraperitoneally) or vehicle, and 
daily for seven days with either MgSO4 (270mg/kg intraperitoneally) or saline. A blood glucose level above 15mmol/L was taken as the threshold for 
diabetes. In-vivo tail pulse plethysmography was recorded for heart rate variability (HRV) analysis and ex-vivo Langendorff perfusion-based left ventricular 
(LV) pressure-volume response parameters were recorded using a PowerLab data-acquisition system. 
Results and conclusion: Mg2+ treatment improved diabetes-induced reduction in heart rate, root mean square of successive differences in NN 
intervals (RMSSD), high frequency (HF) power and low frequency/high frequency power (LF/HF) ratio (p<0.05, n=7/group), suggesting restoration of 
HRV. Mg2+ also improved the head-up-tilt orthostatic stress response in heart rate and LF/HF ratio (p<0.05, n=7/group). Mg2+ reversed the diabetes-
induced right shift in the end-diastolic equilibrium volume intercept (V0) from 49 ± 6μl to 25 ± 5μl (p=0.014, n=6/group), without altering the LV 
developed pressure. Mg2+ treatment did not reverse diabetes-induced hyperglycaemia. These results suggest that Mg2+ pre-treatment may protect 
against diabetes-induced reduction in HRV and shift of LV diastolic pressure-volume response, without altering the degree of hyperglycaemia. These 
fi ndings point toward a potential therapeutic role for Mg2+ in diabetes-induced cardiac disease.
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Predictive value of a 12-lead ECG in an African population with pulmonary hypertension: Data from the 
Pan African Pulmonary hypertension Cohort (PAPUCO) study
Irina Balieva*, Anastase Dzudie#, Friedrich Thienemann†, Ana O. Mocumbi‡, Lori Blauwet◊, Kamily Karaye§, Mahmoud U. SaniΔ, 
Okechukqu S. Ogah+, Adriaan Voors**, Andre Pascal Kengne∞ and Karen Sliwa∫
* Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa; 
University of Groningen, Groningen, The Netherlands
# Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa; Cardiology Unit, Douala General Hospital, Cameroon; 
Faculty of Health sciences, University of Buea, Cameroon
† Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa; Clinical Infectious Diseases Research Initiative, IDM, 
University of Cape Town, South Africa; Integerafrica
‡Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique
◊Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, United States of America
§Department of Medicine, Bayero University, Kano, Nigeria
Δ Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa; Department of Medicine, Bayero University, 
Kano, Nigeria
+Department of Medicine, University College Hospital Ibadan, Ibadan, Nigeria; Ministry of Health, Umuahia, Nigeria
**University of Groningen, Groningen, The Netherlands
∞  Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa; Non Communicable Diseases Unit, South African Medical 
Research Council
∫Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
Introduction: Pulmonary Hypertension (PH) is a major global health issue. Despite the improvements in understanding PH and the development of 
novel therapies, the condition is still diagnosed at the advanced stage, reducing quality of life and survival. We assessed the diagnostic utility of a standard 
12-lead ECG for PH in resource-limited settings. 
Methods: Sixty-fi ve patients diagnosed with PH from the multi-center Pan African Pulmonary hypertension Cohort (PAPUCO) study were compared 
to 285 heart disease-free subjects from the Heart of Soweto study. Prevalence, sensitivity, specifi city, positive and negative predictive values of ECG 
parameters, indicative of PH and right heart strain, were calculated. 
Results: The most common aetiology was PH due to left heart disease (46%). Compared to the control group, all abnormalities were more frequent 
in the PH cohort. The most prevalent (cases vs. control) ECG abnormalities were: pathologic Q-wave (47.7% vs. 6.7%, p<0.05), left ventricular 
hypertrophy (38.5% vs. 9.8%, p<0.05) and p-pulmonale (36.9% vs. 20.7%, p<0.05). No patient had a completely normal ECG, as opposed to 15% in the 
control group. The sensitivity of ECG criteria for right heart strain ranges between 1.5 and 47.7% while specifi city ranges between 79.3 and 100%. The 
negative predictive value ranges between 81.5 and 88.9%. Positive predictive value was lowest at 25% for RBBB and QRS right axis deviation (≥100°) 
and highest at 100% for QRS axis ≥+100° combined with R/S ratio ≥1 or R in V1>7mm.
Conclusion: ECG abnormalities are common, but non-specifi c, among patients with PH. Furthermore, those relating to right heart strain are less 
frequent. ECG patterns focusing on the R and S amplitude in V1 and right axis deviation had good negative predictive values for PH, but due to high 
prevalence of ECG abnormalities, this should be interpreted with caution. Pending further studies, other tools are needed for screening PH. 
An in vivo study of the extracellular matrix after prolonged cold ischaemic harvesting time comparing 
cryopreservation to decellularisation 
D. Bester*, L. Botes#, J.J. van den Heever*, P.M. Dohmen*,† and F.E. Smit*
*Department of Cardiothoracic Surgery, Faculty of Health Sciences, University of the Free State, Bloemfontein, South-Africa
#Department of Health Sciences, Faculty of Health and Environmental Sciences, Central University of Technology, Bloemfontein, South-Africa
†Department of Cardiovascular Surgery, Charité-Universitätsmedizin Berlin, Germany
Objectives: Cryopreserved pulmonary allografts are still the golden standard for right ventricular outfl ow tract reconstruction, however availability is 
restricted and durability is limited by immunogenic response. This study was performed to investigate the early impact of prolonged cold ischaemic 
harvesting time and decellularisation on pulmonary allografts to improve durability.
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Methods: Two groups of pulmonary allografts were created, both with a post-mortem cold ischaemic harvesting time of 48 hours, including 
cryopreserved pulmonary allografts (CPAs) (group 1; n=5) and decellularised pulmonary allografts (DPAs) (group 2; n=5). Valves of both group were 
explanted after 14 days of implantation in the juvenile sheep model. Integrity of the extracellular matrices of CPAs and DPAs were examined by tensile 
strength (TS) and Young’s modules (YM) test. Histological evaluation of the extracellular matrix included H&E, Picoserius red and transmission electron 
microscopy.
Results: Tensile strength and YM of the wall were, in group 1 (0.48 ± 0.12 MPa, and 0.99 ± 0.16 MPa) and in group 2 (0.96 ± 0.56 MPa, and 0.78 ± 
0.12 MPa) respectively. The leafl et TS and YM were, in group 1 (2.79 ± 1.00 MPa, and 11.47 ± 5.05 MPa) and group 2 (5.64 ± 1.67 MPa, and 36.20 ± 
19.47 MPa) respectively. Histologic examination (H&E and Picrosirius Red staining) demonstrated a well-preserved extracellular matrix in both groups. 
Transmission electron microscopy showed partial destruction of collagen fi bres in the CPAs. The DPAs, however, showed a complete intact extracellular 
matrix with the absence of micro-structural lesions.
Conclusion: This experimental study supports the potential to prolong post-mortem cold ischaemic harvesting time of pulmonary allografts. However, 
if cryopreservation is avoided in favour of decellularisation of pulmonary allografts, micro-lesions of the extracellular matrices can be avoided.
“Blackouts” and sudden death in the apparently well and young - the case of Long QT syndrome: 
Missed opportunities for a diagnosis and treatment 
Paul Brink*, Althea Goosen* and Marshall Heradien#
* Division of Medicine, University of Stellenbosch and Tygerberg Hospital, Bellville, South Africa
#Private cardiologist, Worcester, South Africa
The long QT syndrome (LQTS) is pro-arrhythmic cardiac disorder associated with blackouts (Transient Loss of Consciousness; TLOC). It is necessary 
to recognise that these events are syncope and not epilepsy or another type of attack. Sometimes the syncope-causing ventricular tachycardia may 
degenerate into ventricular fi brillation and death. LQTS is autosomal dominantly inherited and causal-mutations (1 000+) identifi ed in 13 genes. Through 
cascade screening of relatives of 26 LQTS index cases, we identifi ed 203 living persons with the same potassium channel mutation, namely KCNQ1 
A341V. Histories have been collected on all of them. We also collected information on deaths of close relatives. Many, symptomatic with a history of 
blackouts, were not diagnosed with LQTS. We set out to quantitate these missed diagnoses. 
Of the mutation carriers 79% experienced blackouts. Only 26% was diagnosed as LQTS and appropriately treated. Epilepsy was the diagnosis in 40%. 
Another 34% received either laymen’s explanations or medical, “vasovagal”, “sick sinus syndrome”, etc. A number of “near drowning” events were 
documented. Historic deaths before age 20, were 23. Half of these were drownings, all in able swimmers. Other examples are of a girl, aged 13, dying 
on a skating rink while under treatment for epilepsy and a boy, aged 5, who “choked on water”. 
Our experience shows gross disparities in diagnosis and consequent management in a treatable risk of sudden death. Missed opportunities for diagnoses 
ranged from prior to medical encounters to at, and after, the fi rst presentation.  The most common misdiagnosis was epilepsy, in the living, and drowning, 
in the dead. Missed and misdiagnosis may be prevented in how both lay persons and medical professionals perceive TLOC and, also, near drowning 
and drowning events. In the words of one of my teachers:  “You only recognise what you know”.
Infective endocarditis in central South Africa
R. Correia*, D. Bester*, L. Botes# and F.E. Smit*
* Department of Cardiothoracic Surgery, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
#Department of Health Sciences, Faculty of Health and Environmental Sciences, Central University of Technology, Bloemfontein, South Africa
Introduction: Infective endocarditis (IE) is an uncommon disease that carries signifi cant morbidity and mortality despite advances in antimicrobial 
therapy and anaesthetic, surgical and post-operative care in the last three decades. Research regarding surgery for native infective endocarditis (IE) in 
South Africa is limited. The present study is a retrospective analysis of patients with IE requiring surgery in central South Africa between 2006 and 2014.
Method: This study is a retrospective analysis of the demographics, diagnoses, pre-disposing factors, HIV status, pathogens, intra-operative and post-
operative records and clinical outcomes of patients presenting with IE in central South Africa.
Results: Hundred adult patients were operated for IE during this period.  The average age was 43 years (14 - 78 years) with a male predominance 
(60%). In total, 127 valve procedures were performed of which 98 were valve replacements and 29 valve repairs. The procedures included repair or 
replacement of 47 aortic, 60 mitral and 17 tricuspid valves. Organisms were similar to previous studies, with 80% of cases due to Staphylococcus and 
Streptococcus infections. The predominant underlying cause was found to be rheumatic heart disease, with congenital causes being the second most 
common cause.  Thirty-three percent of patients (17/52 patients) who consented to be tested were HIV-positive. The 30-day mortality rate was 8% of 
which 1 patient was HIV+.
Conclusion: IE remains an important surgical disease in the South African population. Rheumatic heart disease predominates as an important cause 
with the second most common cause being congenital heart disease. This prospective study also suggests that HIV does not contribute signifi cantly to 
IE peri-operative mortality rates, but the prevalence of at least 17% in this cohort is higher than previously published data.
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Acute coronary syndrome in South Africans – with a specifi c focus on statin treatment – SA Heart 
SHARE registry results (2004 - 2012) 
Rhena Delport* and Elizabeth Schaafsma#
* University of Pretoria, Pretoria, South Africa
#SA Heart Association, Tygerberg Hospital, South Africa
Introduction: This study investigates acute coronary syndrome (ACS) in South Africans in association with risk factors and other variables, with the 
aim of improving the management of STEMI. Prior admission to Cath lab treatment with statins is scrutinised in relation to ACS sub-type, indication for 
treatment and other relevant factors. 
Method: ACS phenotype (ASC-p) was defi ned by clinical subtype and prior intervention and 10 498 of 15 243 admissions to Cath labs were defi ned 
as such. Data on ethnicity were only available for 5 747 ACS-p patients and data on location of centre for 9 985 patients. Prior medication prescribed 
was reported upon for 6 198 patients. 
Result: STEMI was most prevalent in subjects from African ascent (AA) (18%), Stable Angina Pectoris (SAP) in Caucasians (59%) and Non-STEMI (NS) 
in patients from mixed ancestry (MA) (42%). Family history of heart disease and diabetes was highest in Indian males (59% and 39%), and hypertension 
in AA males (72%). Statin treatment was reported in 54%, 66%, 73% and 77% in Caucasian, AA, MA and Indian patients respectively, and in 41%, 35% 
and 44% of STEMI, SAP and NS patients. Risk for STEMI in ACS-p patients increased by 20% per three-year period (RR 1.2; 95% CI 1.1-1.3) and was 
not ameliorated by statin treatment, which increased from 37% to 57% during the fi rst and last tertile of the study. More patients were diagnosed with 
STEMI in public vs. private centres (15% vs. 7%) during 2010 - 2012, while more patients were treated with statins in public centres (68% vs. 49%). 
Conclusion: STEMI cases appear to be on the increase in public centres, despite a higher percentage of patients being treated with statins. This 
relationship needs to be explored in greater detail, taking the duration of treatment and ancestry into consideration. 
Are sutureless aortic valves suitable for very high-risk patients suffering from active infective aortic 
prosthetic valve endocarditis? 
P.M. Dohmen*,#, J. Konertz*, E. Ewais*, M. Laule†, K. Stangl† and W. Konertz*
* Department of Cardiovascular Surgery, Charité-Universitätsmedizin Berlin, Germany
#Department of Cardiothoracic Surgery, University of the Free State, Bloemfontein, South Africa
†Department of Cardiology and Angiology, Charité-Universitätsmedizin Berlin, Germany
Introduction: Sutureless aortic valves are easy to handle and therefore we evaluated the patient benefi ts of these bio-prostheses in very high-risk 
patients with active infective aortic prosthetic valve endocarditis.  
Materials and methods:  Between April 2014 and July 2015, a total of 42 patients received a sutureless Perceval aortic valve (Sorin Biomedica Cardio 
Srl, Saluggia, Italy) for different indications. Four of these patients, with a median age of 63 years (range 47 - 74 years) suffered from active infective 
aortic prosthetic valve endocarditis, including TAVI. The median euroSCORE II of this highly selected patient cohort was 75.9 % (range 73.7 - 87.7 %). 
Patients were followed and measured, including operative data and early in-hospital morbidity and mortality.  
Results: All patients needed abscess closure with pericardium. Two patients underwent left atrial appendix closure, one left ventricular thrombectomy, 
one coronary bypass grafting and one partial aortic arch redo was performed. Median aortic cross-clamp and cardiopulmonary bypass time was, 
respectively 54 minutes (range 30 - 88 min) and 85 minutes (range 52 - 133 min). The median intubation time was 13 hours (range 7 - 19 hours). Post-
operative morbidity in these very high-risk patients were, reintubation due to extensive delirium in one patient, re-exploration in one patient, temporary 
dialysis in one patient and one patient with sternal refi xation. No pacemaker implantation was needed. There was one in-hospital death (25%).
Discussion: Sutureless aortic valve replacement, in very high-risk patients suffering from active infection aortic prosthetic valve endocarditis, seems to 
be an option with limited morbidity and acceptable mortality.
Beta-blockers in pregnancy: University of Cape Town cardiac diseases maternity cohort study 
Wentzel Dowling, Karen Sliwa, Ayesha Osman and John Anthony
Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
Background: Data regarding the use of beta-blockers in pregnant women with structural heart disease, pertaining to fetal growth restriction and fetal 
outcomes, are limited. We investigated the impact of beta-blockers use in pregnancy on offspring outcome.
Methods: A prospective cohort study was conducted in a tertiary multidisciplinary maternal care facility in South Africa from 2010 to 2012. From 124 
consecutive pregnant women with structural heart disease, 19 received beta-blockers (n= 9) in pregnancy. Poor fetal outcome was defi ned as: perinatal 
death, low birth weight (LBW), Apgar scores <7 and premature birth (<38 weeks). In addition, fetal outcomes of patients with cardiomyopathies were 
compared to other cardiac diseases in pregnancy.
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Results: Fifteen percent (19/124) of patients were on beta-blockers throughout pregnancy. There was no statistical difference in the offspring 
birthweight of women receiving beta-blockers (BB) vs. non beta-blockers (NBB) (2 842.8kg vs. 2 853.2kg, p=0.92). There was an increased risk of LBW 
babies in mothers on BB of 18.6% (RR:1.186, CI:0.38 to 2.58). No association was found between length/dose of BB used in pregnancy and LBW or 
poor fetal outcomes. Forty percent (8/19) of patients with cardiomyopathies were on BB during pregnancy, compared to 10% (11/104) of patients with 
other cardiac diseases (p=0.025). Cardiomyopathy patients’ mean birthweight on BB was less than that of patients with other cardiac diseases on BB 
(2 810.7kg vs. 3 024.5kg, p=0.55). No adverse fetal events were found in the cardiomyopathy group and Apgar scores were 8 and 9.2 respectively with 
good outcomes.
Conclusion: Beta-blockers in pregnancy were found to have a minor impact on fetal birthweight, but had no impact on other fetal outcomes. This 
suggests that we should balance fetal risk with maternal need when considering beta-blocker use in pregnant women with structural heart disease.
Ethnic differences in heart failure:  The New Zealand Maori and Pacifi c Islanders
Raewyn Fisher
Waikato Hospital, Hamilton, New Zealand (on behalf of NZHF Registry Investigators)
Introduction: Differences in heart failure (HF) prevalence, outcome and management exist across the world. Some of these relate to economic 
factors and health care opportunities. Within one country however, signifi cant differences seem to primarily relate to ethnicity. Such disparities exist in 
HF patients within New Zealand (NZ), a country with a predominantly European population. Between 10 - 25% of the population, depending on region, 
are of Maori or Pacifi c Island (M/PI) ethnicity.
Method: For approximately 10 years, data have been collected on HF admissions across NZ (NZ HF Registry). An increasing number of consecutive 
admissions in more recent years provide confi dence that the data collected is representative of national demographics and outcomes.
Results: Compared to NZ European HF admissions, M/PI patients are more likely to be male and on average 17 years younger (62 vs. 79 years). They 
are more likely to have reduced ejection fraction and diabetes, are less likely to have coronary artery disease. These demographics are more similar to 
African, rather than European and American HF registries. 
Due to the incidence of rheumatic heart disease amongst this ethnic population, a greater number of HF presentations are associated with valve disease.
Differences are also noted in medication adherence (poorer in M/PI) but no difference in prognostic medication prescription, and re-admission at 
90 days.
Conclusions: Registries suggest NZ Maori and Pacifi c Islander HF patients are more similar to African than European and American patients. NZ ethnic 
differences in HF aetiology and demographics at admission are seen, especially age. Once admitted, management and outcomes are similar. Focus is 
needed on prevention, identifi cation and management of risks and early disease.
Peripartum cardiomyopathy: Experiences in a low resource setting
Ellise Gambahaya*, Jonathan Matenga*, David Kao#, Golden Fana* and James Hakim*
* University of Zimbabwe College of Health Sciences, Harare, Zimbabwe
#University of Colorado, Denver, Colorado, United States of America
Introduction: Peripartum cardiomyopathy (PPCM) is a rare, but devastating, complication of pregnancy. Although relatively common among African 
women, there is limited outcome data from Africa. We sought to evaluate clinical outcome and risk factors for adverse outcomes among patients with 
PPCM in Zimbabwe.
Methods: A prospective cohort study of patients with PPCM was carried out at a tertiary hospital in Zimbabwe. Clinical assessment and echocardiograms 
were performed at enrolment and at 6 months. Baseline characteristics associated with the primary outcome [a composite of death, left ventricular 
ejection fraction (LVEF) <50%, New York Heart Association (NYHA) functional class III/IV at 6 months] were determined.
Results: Fifty-seven patients with a new diagnosis of PPCM were recruited. Twenty-nine patients (51.8%) had an adverse outcome. Seven patients 
(12.3%) died. Factors associated with adverse outcomes were lower maternal age (OR 0.89, 95% CI 0.80-0.99, p=0.025), NYHA III (OR 10.9, 95% CI 
2.69-43.9, p=0.001), onset of symptoms after the postpartum period (OR 3.57 95% CI 1.06-12.1, p=0.040), increased left ventricular end systolic 
dimension (LVDs) (OR 1.15, 95% CI 1.03-1.29, p=0.014) and lower LVEF (OR 0.92, 95% CI 0.86-0.98, p=0.015). Seven of the 8 patients with thrombotic 
complications had the primary outcome (p=0.052). Forty-three patients had echocardiography at 6 months; 21 (48.8%) experienced complete recovery 
of left ventricular function defi ned as LVEF >50%. Overall, LVEF improved signifi cantly (baseline 29.7 ± 9.9% to 44.5 ± 14.2% after 6 months, p<0.001).
Conclusion: A substantial proportion of patients fully recovered left ventricular function, but adverse outcomes, including mortality were frequent. 
Lower maternal age, worse NYHA functional class, onset of symptoms after the postpartum period, increased LVDs and reduced LVEF at baseline were 
associated with adverse outcomes.
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Radiofrequency catheter ablation in infants and children:  A single centre experience
Adele Greyling, Joris Ector, Marc Gewillig, Rik Willems and Christophe Garweg
UZ Leuven, Leuven, Belgium
Background:  Diagnosis and treatment of paediatric cardiac arrhythmias remain challenging. Antiarrhythmic drugs, beta-blockers, class Ic and class III 
drugs were the only treatment available for many years. Radiofrequency (RF) catheter ablation was introduced for adult patients in 1981 and has been 
applied in children since 1989. Many questions still remain regarding the effi cacy and safety in paediatric patients.
Method:  A retrospective analysis of patient records of patients, 12 years of age and younger who underwent RF catheter ablation was performed.
Results: From January 2011 - July 2015, a total of 51 ablations were performed in 44 patients younger than 12 years of age; mean age was 7 years 
(range 3 weeks - 12 years) with 11 (21.5%) aged 2 years or younger ; mean weight of 16.5kg (range 3.4 - 56kg); average screening time 33.5min 
(SD ± 22.7) and average radiation dose of 37mGy (SD ± 436.52). Echocardiography was normal in 32 (72.7%) of patients. All cases were done under 
general anaesthesia. Diagnosis on invasive electrophysiological study: atrioventricular re-entry tachycardia in 26 (50.9%), atrial ectopic tachycardia in 7 
(13.7%), intra-atrial re-entry tachycardia in 5 (9.8%), atrioventricular nodal re-entry tachycardia in 11 (21.6%) and ventricular tachycardia in 2 (3.9%) of 
cases. RF ablation was successful in 44 (86.3%) of procedures with recurrence rate of 13.7%. No signifi cant complications were noted.
Conclusion:  RF catheter ablation can be performed safely and effectively in even the very young infant. The recurrence and complication rates are 
similar to those reported in adults. Therefore, RF ablation should be the treatment of choice in paediatric patients with serious arrhythmias.
Supracardiac total anomalous pulmonary venous drainage in an asymptomatic adult: The importance 
of pulmonary vein localisation in atrial septal defect assessment 
Bradley Griffiths, Jane Moses and Anton Doubell
University of Stellenbosch and Tygerberg Hospital, Bellville, South Africa
Introduction: Total anomalous pulmonary venous drainage (TAPVD) is a cyanotic congenital abnormality in which all 4 pulmonary veins fail to connect 
to the left atrium (LA), resulting in drainage of the entire pulmonary venous return to the systemic venous circulation. It is the fi fth most common 
cyanotic congenital heart condition (incidence: 0.6 - 1.2 per 10 000 live births). (1) There are 4 anatomic variants (supracardiac, cardiac, infracardiac and 
mixed) that determine where oxygenated pulmonary venous blood mixes with deoxygenated blood from the systemic system. Right-to-left shunting 
usually occurs through an atrial septal defect (ASD). TAPVD presents almost exclusively in infancy and, if untreated, carries a 80% mortality at one year. 
(2) We report an asymptomatic case presenting at 18 years.
Case: Our patient was referred to adult cardiology at Tygerberg Hospital for evaluation of presumed rheumatic heart disease. He reported always 
being physically well and even playing wing for his local rugby team. He was acyanotic and cardiac examination suggested an ASD. Transthoracic 
echocardiography confi rmed a secundum ASD with marked right heart enlargement. A large venous structure was visible anterior to the descending 
thoracic aorta. On transoesophageal echocardiography no pulmonary veins were visible entering the LA. Cardiac catheterisation demonstrated 
supracardiac TAPVD with all 4 pulmonary veins draining into a confl uent chamber, posterior to the LA, which connected via a vertical vein to the 
innominate vein. The Qp:Qs was 4 and the pulmonary vascular resistance was 1 wood unit. Computed tomography scan confi rmed the anatomy. Our 
patient is acyanotic due to preferential streaming of oxygenated blood across the ASD into the LA and is awaiting corrective surgery.
Discussion: It is rare for TAPVD to present undiagnosed in adulthood. Secundum ASD is a common echocardiographic diagnosis that should always 
prompt a search for associated congenital abnormalities, such as partial or total anomalous pulmonary venous drainage. 
References: 1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2. 2002; 39:1890. 
2. Ward KE, Mullins CE. Anomalous pulmonary venous connections, pulmonary vein stenosis, and atresia of the common pulmonary vein. In: The science 
and practice of paediatric cardiology, Garson A Jr, Bricker JT, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998. p.1431.
An unusual cause of a reversible dilated cardiomyopathy 
Willy Hendson
Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa
Hypocalcaemia is a well-known, although rare, cause of a dilated cardiomyoapthy that may occur in infants and children. Causes of the hypocalcaemia 
may be varied, but may include rickets and prematurity.
Patient TM, who is now a 13-year-old male, presented for the fi rst time to our hospital in biventricular failure at the age of 10 years. He had had 
symptoms since the age of 5 years and was examined in private practice, but no cause was found. On echocardiography, a dilated cardiomyopathy with 
an ejection fraction of 32% was diagnosed but with no obvious cause found. He was started on anti-failure therapy and discharged well. He then 
presented for the second time with a seizure when hypocalcaemia was documented. The low calcium was treated, and a full etiologic workup was done. 
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Normocalcaemia was established, on Vitamin D and calcium supplements, with demonstration of the LV function returning to normal over subsequent 
visits. However, he presented again years later to a private hospital with neurologic symptoms and a MRI Brain showed bilateral basal ganglia calcifi cation. 
The signifi cant endocrine abnormality that has been documented in this child, is that of a markedly raised parathyroid hormone (PTH), consistent with 
a diagnosis of pseudohypoparathyroidism. 
Congenital Rubella syndrome – not gone, not to be forgotten 
Willy Hendson* and Michelle Koch#
*Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa
#Charlotte Maxeke Academic Hospital, Johannesburg, South Africa
Rubella is endemic to South Africa, with clusters often occurring in autumn and spring. Although it is a preventable condition, rubella immunisation is 
not part of the EPI programme. It is not a notifi able condition, although congenital rubella syndrome (CRS) is.
WHO Global estimates in 2008 of the burden of rubella suggest that the number of infants born with CRS exceeded 1 100 001 which makes rubella 
a leading cause of preventable congenital defects, the bulk of cases occurring in the South East Asian and African regions. In the WHO African region, in 
1996, it was estimated that >22 500 infants are born with CRS annually. 
The exact incidence of congenital rubella syndrome in South Africa is unknown, but it is estimated that 600 - 700 cases occur annually.
Congenital rubella syndrome is a devastating condition, presenting with the classical triad of cataracts, deafness and cardiac defects. 
A series of 3 patients are presented, highlighting the clinical aspects of this condition which often exacts a comparatively heavy cost to families and to 
strained healthcare systems, when a cheap vaccine is available.
Renal denervation reduces offi ce blood pressure in a sham-controlled trial after one year follow up 
Marshall Heradien*, Bonke Khwinani#, Chris Greyling*, Warren Stillwaney*, Warren Fransman†, Rene Janse van Rensburg*, 
Siyolisi Sibeko* and Paul Brink*
* Department of Internal Medicine, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital, Bellville, South Africa
#SA Endovascular, Netcare Kuilsriver Hospital, Sonnekuil, Cape Town, South Africa
†Department of Pharmacology, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital, Bellville, South Africa
Introduction: One large randomised sham-controlled reneal denervation (RD) trial, SYMPLICITY-HTN-3, could not demonstrate a signifi cant 
reduction in offi ce blood pressure at one year follow up. Incomplete renal denervation has been suggested as one of the reasons for its failure. We tested 
the hypothesis that RD would signifi cantly reduce offi ce blood pressure when compared to sham-controls, if performed correctly. 
Methods: We performed bilateral four quadrant RD in 10 patients who had an offi ce or 24 hour ambulatory blood pressure of ≥160/90mmHg in 
non-diabetics or ≥150/90mmHg in diabetics. All patients ≥55 years were on ≥3 antihypertensive agents, including a diuretic. They had to be in sinus 
rhythm and have echocardiographic evidence of hypertensive heart disease (enlarged left atrium with left ventricular hypertrophy). Patients with 
untreated thyroid disease, signifi cant valvular heart disease and renal impairment (eGFR <45ml/min/1.73m2) were excluded. Offi ce blood pressure was 
measured electronically at least 5 minutes prior to an exercise stress test at baseline and one year after the intervention. Responders were defi ned as 
those with an SBP reduction of ≥5mmHg at follow up. A paired T-test, with equal variance, was used to assess statistical signifi cance and a p-value of 
<0.05 was considered signifi cant.
Results: Age, sex, blood pressure medication and ambulatory blood pressure measurements did not differ signifi cantly. Eleven subjects underwent sham 
RDN. Offi ce systolic blood pressure was signifi cantly reduced in the RD treated group only after one year follow up (SBP_RD1 = 143,2 ± 16.39mmHg 
vs. SBP_RD2 = 130.7 ± 18.2mmHg at one year follow up; with absolute reduction of 12.5mmHg vs. SBP_sham-RD1 = 132.09 ± 14.43mmHg vs. 
SBP_sham-RD2 = 140.18 ± 16.63mmHg at one year follow up; with absolute increase of 8.1mmHg; p=0.0361). Offi ce diastolic BP was only reduced in 
the intervention group: DBP_RD1 = 84.1 ± 10.71mmHg vs. DBP_RD2 = 77.9 ± 8.56mmHg at one year follow up; with absolute reduction of 6.2mmHg 
vs. DBP_sham-RD1 = 76.55 ± 6.47mmHg vs. DBP_sham-RD2 = 83 ± 8.59mmHg at one year follow up.
Conclusion: Offi ce blood pressure was signifi cantly reduced by RD after one year of follow up. Larger trials are awaited to confi rm these results.
205
Sp
rin
g 
20
15
Vo
lu
m
e 
12
 •
 N
um
be
r 4
Registries and research provide a remedy for public policy; rheumatic heart disease in Namibia 
Christopher Hugo-Hamman*, Liina Sikwaya#, Angeline Bock†, Antoinette Awases† and Norbert Forster‡
*University of Cape Town, Rondebosch, South Africa
#Katatura Hospital, Windhoek, Namibia
†Windhoek Central Hospital, Windhoek, Namibia
‡Windhoek Central Hospital, Ministry of Health and Social Services, Windhoek, Namibia
Background: Although prevalence is high (30/1 000 in children 7 - 17 years), Rheumatic Heart Disease (RHD) is much neglected in Africa. Before the 
registry, the burden of RHD in Namibia was unknown with no data to inform public policy. We report data which informed the development of a 
National Programme (ASAP) for the prevention and control of RHD. 
Materials and methods: The national registry of RHD was established at Windhoek Central Hospital in January 2010. From January 2010 - 
December 2014, 463 patients were enrolled in this prospective, national, hospital-based registry. Questionnaires document demographics, presentation, 
complications, ECG, echocardiogram and management. Baseline data is presented on the fi rst 281 patients entered into Remedy.
Results: Distribution of cases refl ects population density, 61% are female and 39% male. Ninety-seven (34%) are children and 83% under 40 years. 
Thirty-two percent were NYHA III - IV and 48% in heart failure. Nineteen percent had atrial fi brillation, 6% stroke and 13% previous surgery. Only 34% 
of patients were receiving secondary penicillin prophylaxis. Of patients needing anticoagulation, 39% were receiving warfarin, 73% had no INR analysis 
the preceding 6 months. Only 7 of 47 who had had surgery, had mitral valve repair. 
Conclusions: The burden of disease is signifi cant. Patients are seen late with advanced disease. Low numbers over 50 years of age (4%) refl ect high 
mortality. Low numbers on secondary penicillin prophylaxis and poor compliance with anticoagulation protocols refl ect a lack of awareness about RHD 
amongst health workers. Gaps identifi ed in the organisation and delivery of care pointed to the need for a national programme for the prevention and 
control of RHD, established in March 2014. A national Advisory Committee for RHD was established in May 2015. This example of “research to action”, 
emphasises the public policy benefi ts to be gained from clinical science.
  
Why they survive? Native congenital heart disease in a grown-up African population without 
access to care 
Christopher Hugo-Hamman*, Paul Barnho# and Henning du Toit†
*University of Cape Town, Rondebosch, South Africa
#Windhoek Central Hospital, Ministry of Health and Social Services, Windhoek, Namibia
†Roman Catholic Hospital, Windhoek, Namibia
Objectives: We describe 104 patients with congenital heart disease (CHD), older than 13 years, from an environment with no cardiac services. 
Methods: Case notes of patients seen at Windhoek Central Hospital, between January 2009 and December 2013, were reviewed for CHD. Clinical 
features, ECG, chest X-ray, echocardiogram, catheterisation, operation and follow-up records were analysed. Diagnosis was established by echocardio-
gram. Surgery was conducted at Windhoek Central or Christiaan Barnard Memorial Hospital. 
Results: In 104 patients, age 13 - 86 years (mean 25), 68 were female. Pathology included: VSD 30, secundum ASD 32, PDA 12, AVSD 10 
(9 primum ASD), AS 4, coarctation of aorta 5. Cyanotic disease included Tetralogy of Fallot 7 (TOF), DORV with TOF 4, PS 7, Ebstein’s anomaly 2 and 
TGA/VSD/PS 2. 
Thirty-one had undergone cardiac catheterisation. Seventy-eight were deemed “operable”. There were 7 interventions for : coarctation (2), PDA (2), 
ASD (2) and valvular PS (1). Surgery was performed on 52: VSD 15, ASD 2 16, PDA 5, primum ASD 5, TOF 6 (3 with DORV). Three with complex 
disease were repaired. Eleven were inoperable. 
Over 5 year follow-up (mean 32 months), three patients died: 2 with inoperable secundum ASD and 1 after shunt surgery for TOF with pulmonary 
atresia. Fifteen patients were lost. 
Conclusions: This cohort refl ects a time with no diagnostic or curative services for CHD. A high number of patients with large, “simple” lesions (VSD, 
ASD and PDA), advanced pulmonary hypertension and congestive cardiac failure are still operable. There is a sub-set of patients with Tetralogy of 
Fallot who survive to adulthood. Their anatomy and the surgical challenge is different from that in the infant. The high number “lost” refl ects system 
challenges in a vast, low income country.
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The use of mechanical heart valves without anticoagulation.  A bridge too far?
C.J. Jordaan*, L. Thompson-Jooste*, D. Bester*, J.J. van den Heever*, R.W.M. Frater# and F.E. Smit*
* Deptartment of Cardio Thoracic Surgery, University of the Free State, Bloemfontein, South Africa
#Albert Einstein College of Medicine, Bronxville, New York, United States of America
Objective:  The thrombogenicity of mechanical prosthetic heart valves limit their use. Patients are subjected to lifelong warfarin use, balancing bleeding 
risk with thrombosis. Designing a valve that will negate the use of warfarin remains the Holy Grail in mechanical valve design research.  The thrombotic 
properties of a re-engineered valve design (the UCT/Frater valve) were tested in the ovine model to assess its thrombogenic potential.
Methods: The UCT valve was modifi ed along modern fl ow dynamic principles and designs. These valves were implanted in the pulmonary position 
during 2013 - 2014 in the juvenile ovine model (males, mean age 6 months). Sorin Carbomedics mechanical prostheses were used as control valves. The 
study population was divided into two groups, based on post-operative follow up (Group1=6 month and Group 2=12 month follow-up).  A total of 12 
pulmonary valve replacements were performed. Each group consisted of 1 control (Carbomedics) and 5 UCT/Frater valves. No coumadin or anti-
platelet therapy was used throughout the study interval. 
Full blood counts, liver functions, haptoglobin, platelet activation and fragmentation were performed during follow-up and macro- and microscopic 
inspection upon explantation.
Results: Two UCT/Frater valves thrombosed secondary to infective endocarditis (IE). None of the other valves, control valves included, showed any 
macroscopic or microscopic thrombi. Biochemistry and hematology did not demonstrate hemolysis, activation of coagulation or platelet activity. 
Histology showed no thrombi on the sewing cuff, housing, poppet or struts. None of the subjects had embolic events and their lungs had no pulmonary 
emboli. Cardiac echocardiography confi rmed normal prosthetic function in all valves, except those with IE.
Conclusion:  The re-engineered UCT/Frater valve design, without anticoagulation and anti-platelet treatment, performs well in the ovine model with 
acceptable haemodynamics. This prosthesis should be tested in a more aggressive coagulation model.
Scimitar Syndrome case series
Michelle Koch* and Willy Hendson#
*Charlotte Maxeke Academic Hospital, Johannesburg, South Africa
#Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa
Introduction: Scimitar Syndrome is a rare congenital anomaly, a form of Partial Anomalous Pulmonary Venous Drainage. The typical anatomy 
comprises of the right pulmonary venous return draining into the inferior vena cava, amongst other associated abnormalities. The name is derived 
from the similarity in shape of the vein to a scimitar blade. There is a bi-modal presentation, with infantile types presenting early with cardiac failure, 
pulmonary hypertension and signifi cant mortality.
Cases: We present a series of 3 cases seen at our hospital from 2004 - 2015.
All 3 cases were female, had common fi ndings of a chest X-ray showing dextroposition, a hypoplastic right lung and, on angiography, the classical Scimitar 
vein draining into the inferior vena cava.
The younger patient, aged 5 months, presented with heart failure and signifi cant pulmonary hypertension, whereas the 6-year-old and the 9-year-old 
were far less symptomatic. The six-year-old was the only patient who had an associated intra-cardiac defect, namely an Atrial Septal Defect. The 5-month-
old and the 9-year-old had collateral arterial supply to the right lung and both were subsequently occluded during catheterisation.
The 5-month-old was lost to follow up after coiling of the collateral arterial supply. Surgical correction was successfully done in the 6-year-old and 
the 9-year-old is awaiting surgery.
Discussion:  The aim of this case series is to review this unusual congenital anomaly and highlight the clinical, radiologic and management aspects.
Cardiac transplantation vs. mechanical cardiac support: Current status in South Africa
Willie Koen, Otto Thaning, Leisch Horak, Anton Ferreira, Heinz Modler, Alistair Arenson, Lisa Arenson, Dene Friedman, 
Helena Williams, Karen Tilney and Sarel Koen
Heart Transplant and Mechanical Heart Programme, Christiaan Barnard Memorial Hospital, Cape Town, South Africa
Introduction: Although donor heart transplantation is still considered to be the gold standard in the treatment of end-stage cardiac failure, technological 
advances are progressively becoming a more attractive option. This abstract reports on the activities and current status in long-term mechanical cardiac 
support in South Africa.
Method: Over the past 15 years, 46 patients were supported with mechanical assist devices. Nine patients were successfully treated using the 
HeartWare ventricular assist pump during the past 3 years as a bridge-to-transplantation. Twenty-eight patients were supported using the Jostra 
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Centrifugal pump. Twenty-four of these patients had post cardiotomy shock following coronary artery surgery. Four patients had donor heart failure at 
the time of transplantation. Nine patients received Berlin Heart BiVAD implantation. Ages ranged from 11 - 61 years.  The respective indications and 
techniques of implantation and post-operative management are discussed.
Results: Seven of the nine patients (78%) receiving the HeartWare device were discharged and all 7 are back at work.  Of the 28 patients who received 
the Jostra centrifugal pump, 24 (84%) were weaned off and 22 (79%) were discharged from hospital. Of the 9 patients on the BiVAD Berlin Heart, 
7 (78%) patients were transplanted and 6 (67%) discharged from hospital. All 3 patients of the 4 requiring donor heart support were successfully 
weaned and discharged home.
Conclusion: These results compare favourably with the outcomes reported upon in international literature. Due to organ shortage in South Africa, 
an increase in demand for mechanical assistance can be expected in the future. 
The integrity of the coronary artery after cardiac transplantation:  A review of the challenges to the 
transplant team in 150 cardiac recipients
Willie Koen, Helena Williams, Basil Levetan, Faizel Lorgat, Susan Vosloo and Otto Thaning 
Christiaan Barnard Memorial Hospital, Cape Town, South Africa
Introduction: Coronary artery disease is an indication for cardiac transplants in 45 - 50% of reported cases. After the transplant, transplant related 
coronary disease is the leading cause for late mortality. Several factors contribute to the development of transplant vasculopathy, of which tissue 
mismatch, CMV exposure, poor rejection control, diabetes, serum lipid profi le and atherosclerosis are leading causes.
Interventions, such as percutaneous intervention (PCI), coronary surgery and transmyocardial laser revascularisation can be used to improve myocardial 
perfusion. Intravascular ultrasound (IVUS) can be useful in the diagnosis, quantifi cation and management of transplant coronary artery disease. 
Method: Hundred-and-fi fty patients which receive cardiac transplants, over a period of 15 years, were reviewed. All 150 patients had annual routine 
coronary angiograms. Seventy-fi ve patients had angiographical evidence of coronary pathology, post transplantation. One patient presented with angina 
and 23 patients with deteriorating ventricular function. Twenty-four required percutaneous coronary intervention. One patient had a transmyocardial 
revascularisation procedure. One patient had coronary artery bypass surgery. 
Results: Of the 75 patients, 2 (3%) patients showed evidence of regression on medical therapy. Of the 24 patients requiring PCI 4 (32%) patients 
needed repeat PCI and 2 patients required repeat transplantation (3%). The 2 (3%) patients that underwent CABG and TMLR died. 
Conclusion: As transplant vasculopathy is a leading cause of mortality in the transplant recipient, the integrity of the coronary artery forms a 
cornerstone of long-term management of the cardiac recipient. A team approach, as well as a sound understanding of drug interaction, is required to 
minimise development of transplant related vasculopathy. 
Albuminuria is related to troponin in hypertensive black women 
Ruan Kruger
Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa
Objective: In hypertensives, troponin T, as a marker of cardiomyocyte damage, predicts the development of renal disease as refl ected by micro- and 
macro-albuminuria. However, urinary albumin excretion also refl ects general endothelial damage and relates to arterial stiffness, which in turn increases 
cardiac afterload and damage. We investigated the link between troponin T and albuminuria in black women, without renal dysfunction, but in which 
hypertensive heart disease is common.
Design and method: This sub-study included a cohort of 122 black women (mean age: 60.6 years) from the larger Prospective Urban and Rural 
Epidemiology study. ECGs, along with conventional cardiovascular assessments, were performed. Biochemical analyses included urinary albumin and 
creatinine, and serum troponin T. We assessed renal function with estimated creatinine clearance and glomerular fi ltration rate (eGFR).
Results: In bivariate analysis, ACR correlated positively with the Cornell-product, central systolic blood pressure, central pulse pressure, aortic pulse 
wave velocity and troponin T (all p<0.05). After adjusting for age, body surface area, hypertension status and eGFR, the results remained unchanged 
for troponin T (r=0.30; p=0.010) and the Cornell-product (r=0.27; p=0.028). After performing a multiple regression analysis, we observed the same 
trends, however with a signifi cant interaction with hypertension status (F=14.3; p=0.031). When repeating the same model in hypertensives only, 
troponin T associated with ACR (Adj. R2=0.48; ß=0.55; p=0.006). This was not the case for normotensives.
Conclusion: Troponin T was positively associated with albuminuria in hypertensive black women. Our result indicates that albuminuria, even in normal 
range, is linked to adverse cardiomyocyte damage in non-diabetic hypertensive black women, possibly via the increased arterial stiffness – cardiac 
overload mechanism.
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Comparison of the clinical phenotype of the common heterozygous familial hypercholesterolaemia 
mutations at the LDL-receptor in the Afrikaner population
Robert Mark Leibbrandt and Frederick Raal
University of the Witwatersrand, Johannesburg, South Africa
Introduction:  It has been previously reported that South African whites have one of the highest death rates from coronary artery disease in the 
Western world. The reasons for this are likely multifactorial but one of the proposed reasons is the high prevalence of familial hypercholesterolaemia 
(FH) in this patient population. The 3 most common mutations occurring at the LDL receptor are designated Afrikaner 1 (FH1), Afrikaner 2 (FH2) and 
Afrikaner 3 (FH3). Little is known regarding the clinical phenotype of these patients with only one study to date with very small numbers being published.
Methods: A retrospective analysis from 1981 - 2015 was undertaken at the Lipid Clinic of CMJAH. All patients heterozygous for FH1, FH2 and FH3 
mutations were analysed by fi le review.
Results: Four-hundred-and-ninety-two patients were analysed, 200 males and 292 females. Two-hundred-and-eighty-six patients were FH1, 183 were 
FH2 and 23 were FH3. The average age at diagnosis was 36 years with FH2 patients tending to present younger and FH3 patients older. The average 
total cholesterol at diagnosis was 8.9mmol/L for FH1, 9.5mmol/L for FH2 and 8.1mmol/L for FH3. This difference was signifi cant (p=0.0038) amongst 
the 3 groups and between FH2 and FH3 (p<0.01). The prevalence of ischaemic heart disease was 24% in FH1, 22% in FH2 and 13% in FH3 which was 
not signifi cant for difference amongst the 3 groups.
Conclusion: This review is the fi rst of its kind to compare the phenotypic severity of the 3 most common Afrikaner mutations. It showed that FH3 
is the mildest mutation in terms of phenotypic characteristics with a signifi cantly lower untreated total cholesterol and prevalence of ischaemic heart 
disease. FH2 appears to be the worst mutation in terms of clinical severity with a higher total cholesterol and prevalence of ischaemic heart disease, 
although this did not achieve statistical signifi cance. 
Comparison of the response to statin therapy in heterozygous familial hypercholesterolaemia within 
the Afrikaner population
Robert Mark Leibbrandt and Frederick Raal
University of the Witwatersrand, Johannesburg, South Africa
Introduction: The 3 most common mutations occurring at the LDL receptor are designated Afrikaner 1 (FH1), Afrikaner 2 (FH2) and Afrikaner 3 
(FH3). These are responsible for 90% of the cases of familial hypercholesterolaemia (FH) within the Afrikaner population in South Africa. Little is 
known regarding the response to lipid-lowering therapy in these patients with only one study to date with very small numbers being published.
Methods:  A retrospective analysis, from 1981 - 2015, was undertaken at the Lipid Clinic of CMJAH. All patients heterozygous for FH1, FH2 and FH3 
mutations were analysed by lipogram assessments at baseline and after 3 months and 24 months of statin therapy (varying doses, however a mean effect 
was calculated within each group). Percentage reduction in total cholesterol was calculated.
Results: Four-hundred-and-ninety-two patients were analysed, 200 males and 292 females. Two-hundred-and-eighty-six patients were FH1, 183 were 
FH2 and 23 were FH3. The average total cholesterol at diagnosis was 8.9mmol/L for FH1, 9.5mmol/L for FH2 and 8.1mmol/L for FH3. The average 
total cholesterol (TC) for at 3 months was 7.3mmol/L (18% reduction) for FH1, 7.5mmol/L (21% reduction) for FH2 and 6.9mmol/L (15% reduction) 
for FH3. At 24 months the average TC was 6.43mmol/L (28% reduction) for FH1, 6.1mmol/L (36% reduction) for FH2 and 5.7mmol/L (30% reduc-
tion) for FH3. The effect of both time (p<0.0001) and type of mutation (p<0.001) was signifi cant. 
Conclusion: This study is the largest of its kind to compare the response to statin therapy amongst the three most common Afrikaner mutations. It 
showed that FH2 patients, although starting at a higher baseline TC, respond signifi cantly better to statin therapy than FH1 and FH3 patients do. 
One year survival of patients with symptomatic dilated cardiomyopathy compared to 
peripartum cardiomyopathy
Kishal Lukhna, Nicholas Rich, Sarah Kraus, Karen Sliwa, Bongani Mayosi and Ntobeko Ntusi
Groote Schuur Hospital and University of Cape Town, Observatory, South Africa
 
Background: Little data are available from sub-Saharan Africa on the clinical characteristics and prognosis of symptomatic DCM. 
Objective: The purpose of this study was to compare the 1 year outcomes of patients with symptomatic DCM compared to those with symptomatic 
PPCM, in a contemporaneous African setting with availability of evidence-based therapies.
Methods: One-hundred-and-forty-six patients were included in the study, comprising 92 DCM patients (51 female, mean age 36.6 ± 9.4 years) and 54 
PPCM patients (mean age 38.4 ± 9.8 years) that were followed up serially between 1 January 2014 and 31 December 2014, in a dedicated specialist 
cardiomyopathy clinic at Groote Schuur Hospital, Cape Town, South Africa. Clinical characteristics, medical therapy, cardiovascular events and mortality 
were compared between the 2 groups.
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Results: There were no signifi cant differences between the baseline clinical features of patients with DCM and PPCM (besides gender). A high 
proportion of patients were treated with evidence-based therapies, including angiotensin converting enzyme inhibitors/angiotensin receptor blockers, 
beta-blockers, aldosterone inhibitors and diuretics and there were no signifi cant differences in the management of DCM and PPCM patients. Patients 
with PPCM had a modest improvement in systolic function (p=0.026) while there was no signifi cant change in the LV ejection fraction (LVEF) of DCM 
patients (p=0.844) over the follow-up period of 1 year. The 1 year case fatality rate of symptomatic DCM was 8.7% vs. 7.4% for symptomatic PPCM 
(p=0.783). In this study, there was no association between LVEF and mortality (p=0.902). Importantly, these data do not refl ect the early outcome of 
PPCM and DCM, often associated with higher mortality. 
Conclusions: The case fatality rate remains high in our setting despite the full application of evidence-based therapies. Our data emphasise the 
importance of individualised follow-up care and long-term continuity of care of patients with cardiomyopathy. 
Genetic contribution to the risk for metabolic syndrome 
Tanya Maistry and Dashana Naidoo
University of KwaZulu-Natal, Durban, South Africa
Introduction: Metabolic syndrome (MS) is associated with lifestyle, environmental and genetic factors, with obesity and insulin resistance (IR) as driving 
factors for its progression.
Aims: To establish the genetic profi les of subjects in the Indian community of Phoenix and to determine genetic patterns associated with MS.
Methodology:  This study investigated 1 000 subjects from the Phoenix Lifestyle Project. MS was diagnosed according to NCEP ATPIII, IDF and 
harmonised defi nitions and IR (HOMA-IR values >2.6). The apolipoprotein A5 Q139X, lipoprotein lipase Hinf I, human paraoxonase 1 192Arg/Gln, 
cholesteryl ester transfer protein Taq1B, adiponectin 45T >G and leptin 25CAG were genotyped by real time PCR.
Results:  The prevalence of MS was high (44.3%: NCEP ATPIII, 51.6%: IDF, 49.0%: harmonised). More females had MS than males [harmonised (51.0% 
vs. 42.8%)]. IR was high in MS subjects (harmonised 76.3%), with more females being IR than males [harmonised (78.3% vs. 69.2%)]. Genotypes/alleles 
of the polymorphisms in MS subjects varied, with no signifi cance detected. Males with adiponectin TG genotype and human paraoxonase 1 AA 
genotypes were more inclined to have reduced HDL-C (harmonised p=0.001) and higher systolic BP (harmonised p=0.02) respectively. IR males 
(HOMA IR values >2.6) with the lipoprotein lipase HinfI (GG genotype) and human paraoxonase 1 192Arg/Gln (AA genotype) were more likely to 
have higher systolic and diastolic BP (harmonised p<0.05). 
Conclusion:  A high number of Indians living in Phoenix have MS. No association between the polymorphisms studied and the risk for MS was 
observed, except for an association with low HDL and hypertension (in males). The genetic risk for MS may lie in its components, rather than in MS as 
an entity.
Depression symptoms and ocular perfusion pressure in black Africans - the eyes and not the carotid tell 
it all:  The SABPA study
Leoné Malan*, Mark Hamer#, Roland von Känel†, Markus Schlaich‡, Wayne Smith*, Manja Reimann◊, Nancy Frasure-Smith§, Gavin 
LambertΔ, Walthard Vilser+, Brian Harvey* and Hendrik Steyn*
*North-West University, Mahikeng, South Africa
#University College of London, England, United Kingdom
†Department Psychosomatic Medicine, Clinic Barmelweid, Barmelweid, Switzerland
‡University of Western Australia, Crawley, Australia
◊Technische Universität Dresden, Dresden, Germany
§University of Montreal, Montréal, Canada
ΔMonash University, Melbourne, Australia
+Imedos, Jena, Germany
Introduction: High pulse pressure exerts sheer stress on vessel walls and may impair carotid and retinal perfusion, contributing to arterial stiffness and 
remodelling. Depression symptoms have been associated with poor prognosis of coronary artery disease and cardiac wall remodelling. We therefore 
aimed to assess the link between depressive symptoms and reduced perfusion to the carotid and the retina. 
Method: A sub-Saharan African bi-ethnic gender cohort (Africans/Men ± 48%), aged 48.6 ± 9 years, was included (n=359). Cardiometabolic risk 
markers were obtained under fasting well-controlled conditions using standardised protocols. Depressive symptoms scores were calculated using 
DSMIV criteria. Ambulatory BP, ECG and ultrasound B-mode carotid far wall measures were obtained. DBP – Intra-ocular pressure defi ned ocular 
perfusion. Cardiometabolic retinopathy conditions were evaluated whilst static and dynamic retinal vascular calibre and responses were quantifi ed from 
digital photographs using standardised protocols.
Result: Africans revealed more depressive symptoms, silent ischaemia, higher 24 hour pulse pressure, retinal remodelling (arteriolar narrowing) and 
augmented venular dilation during fl ickering light, when compared to Caucasians. Overall, depressive symptoms were associated with retinal arteriolar 
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narrowing, but not carotid remodelling in the bi-ethnic cohort. Depressive symptoms and ocular perfusion pressure were associated with a wider 
venular calibre (p<0.01), a stroke risk marker, in Africans only. Ocular perfusion pressure was inversely associated with arteriolar calibre and dilation 
(p<0.01) in African men. 
Conclusion: More depressive symptoms may trigger changes in ocular haemodynamics of the Africans. Reduced perfusion in the eye might act as a 
trigger to increase blood pressure as compensatory mechanism to alleviate reduced supply. The increased risk for stroke in the Africans underscores the 
need for screening of diastolic ocular perfusion pressure and presence of depression symptoms to detect early onset of vascular pathology and potential 
subcortical ischaemia. It may improve insight on the retinal-heart circulation and future stroke.
Infective endocarditis due to intravenous Nyaope use: The beginning of an epidemic? 
Ruchika Meel, Ferande Peters and Mohammed R. Essop
Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
Introduction: Infective endocarditis (IE), secondary to intravenous drug abuse (IVDA), is uncommon in an African population. We recently described 
3 cases of IE secondary to IV Nyaope (variable mixture of heroin, cannabis, antiretrovirals, metampatamines) use. Since then we have encountered an 
additional 21 cases.
Methods: Patients presenting with IE, due to IVDA, at Chris Hani Baragwanath Academic Hospital were included in this prospective case series. All 
underwent echocardiography and additional investigations at the discretion of the treating physician. 
Results: Mean age was 24.8 years (23 males). The majority presented with dyspnea (58%), symptoms of withdrawal (29%), peripheral suppurative 
infection (25%) and right ventricular (RV) failure (8%). Most were HIV reactive (87%) and not on ARVs. Three patients had a CD4 count ≤200 cells/μl. 
All were anaemic with raised infective markers. Renal failure requiring dialysis was present in two patients. Four patients had evidence of prior Hepatitis 
B infection and Hepatitis C antibody were detected in 42%. Staphylococcus aureus was cultured in 58% and Pseudomonas aeruginosa in 1 patient. 
Polymicrobial infection was found in 4 patients. Sterile blood cultures were present in 6 patients. Tricuspid valve endocarditis was present in the majority. 
Concomitant involvement of mitral valve and pulmonary valve was present in the minority. Only one patient had isolated aortic valve endocarditis. 
The mean vegetation size was 12.5mm and 9 patients had pulmonary hypertension and RV dysfunction. Septic pulmonary emboli were documented in 
11 patients. All were treated with antimicrobials and only 3 patients underwent surgery. One patient died within 24 hours of admission secondary to 
respiratory failure.
Conclusion: IE secondary to IVDA is on the rise among young black South Africans and is responsible for morbidity and mortality in this group. A high 
degree of suspicion must be maintained in order to make an early diagnosis and initiate treatment. 
Left atrial volume and strain parameters using echocardiography in a normal sub-Saharan 
African population 
Ruchika Meel*, Ferande Peters*, Elena Libhaber#, Samantha Nel* and Mohammed R. Essop*
*Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
#Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Introduction: Left atrial (LA) volume and function are important predictors of cardiovascular morbidity and mortality. No normative data are available 
for black Africans. Furthermore, patterns of left ventricular (LV) remodelling differ between races. We therefore sought to establish reference values for 
LA volume and strain (ε) in a normal black African population. We thus sought to: (1) establish normative values for LA volumetric and ε parameters 
and (2) determine the effect of age related changes in LV diastolic function on measures of LA function.
Methods: The study comprised 120 normal individuals aged between 18 - 70 years (50% males). LA volumes and ε were measured with biplane 
Simpson’s method and Philips Qlab 9 speckle tracking software. LV diastolic function was assessed using the e/e´ ratio.
Results: The mean age was 38.7 ± 12.8 years. Overall maximum LA volume indexed to BSA (LAVi) was 19.7 ± 5.9ml/m2 and minimum LAVi was 7.7 
± 3.2ml/m2. Peak global longitudinal strain in the reservoir phase (εR) was 39.0 ± 8.3% and the peak strain in the contractile phase was -2.7 ± 2.5%. 
LA pump function increased with age (r=0.2, p=0.02), as the conduit function decreased with age (r=-0.3, p<0.001). εR declined with age (p<0.001). 
More advanced age was associated with decrease in diastolic function (r=0.4, p<0.001).
A positive correlation between e/é lateral and LA conduit and booster pump parameters (r=0.3, p<0.05) was noted. εR correlated negatively with 
diastolic function (r=-0.3, p<0.002). On multivariate regression analysis male gender and e/é lateral were predictors of maximum LAVi (p<0.05). 
Age and e/é medial remained determinants of εR (p<0.05).
Conclusion: LA pump and conduit functions show a compensatory increase with normal ageing as diastolic function worsens. This occurs before 
alteration in maximum LAVi. Additionally, εR may be a more sensitive marker for assessing LA function than maximum LAVi.
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Right ventricular strain using 2D Speckle tracking echocardiography in a normal African population
Ruchika Meel*, Ferande Peters*, Elena Libhaber#, Samantha Nel* and Mohammed R. Essop*
* Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
#Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Introduction: Right ventricular (RV) function is an important prognostic determinant in various cardiovascular diseases. RV strain (ε) is a relatively new 
technique for assessing subclinical RV dysfunction. There is a paucity of data regarding RV ε in a black population. We thus sought to establish: (1) Norma-
tive RV ε data in a black population; (2) determinants of RV ε; and (3) correlation of RV ε with age and RV tissue Doppler parameters.
Methods: A prospective cross-sectional study, comprising 109 normal black African subjects was conducted at CHBAH from 2014 - 2015. The subjects 
were categorised into four age groups: 18 - 29, 30 - 39, 40 - 49 and >50 years. Peak RV free wall ε and tissue Doppler parameters were measured on 
echocardiography (Phillips IE33 and QLAB 9 speckle tracking software). 
Results: The mean age was 36.3 ± 13.2 years (49% females). The RV E´ decreased with increasing age on sub-group analysis (p=0.02). There was a 
negative correlation between RV E´ and age (r=-0.39, p<0.001). RV ε was -19.1 ± 3.5%. There was no difference in ε in between the age categories 
(p=0.059). As the RV ε increased (more negative), the RV systolic function (S´) and early RV fi lling (E´) increased (r=-0.21, p=0.02; r=-0.26, p=0.005). 
On multivariate linear regression analysis, age and RV E´ emerged as the most important predictors of strain after adjusting for gender, RV S´ and systolic 
blood pressure(r=0.4, p<0.001).
Conclusion: We have provided normative data for RV ε in a normal African population. Age and RV E´ were important determinants of peak systolic 
RV free wall ε. This study provides a framework for future risk assessment and prognostication in varied cardiovascular diseases.
The changing spectrum of chronic rheumatic mitral regurgitation in Soweto, South Africa 
Ruchika Meel*, Ferande Peters*, Elena Libhaber# and Mohammed R. Essop*
* Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
#Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Introduction: Previous studies have documented the high prevalence of rheumatic fever and rheumatic heart disease in the population of Soweto 
and have provided a detailed description of the echocardiographic fi ndings in these patients. We sought to determine whether the clinical and 
echocardiographic characteristics of rheumatic mitral regurgitation (MR) had changed in a more contemporary population. 
Methods: This prospective cross-sectional study was conducted at Chris Hani Baragwanath Academic Hospital (CHBAH) between January 2014 and 
October 2014. Eighty-four patients with moderate, or severe, chronic rheumatic MR who met the selection criteria were included in the study. 
Results: The study comprised 84% females with a mean age of 44 ± 15.3 years. Acute rheumatic fever (ARF) was documented in only 1 patient. 
Hypertension and HIV were present in 52% and 26% respectively. Echocardiography showed leafl et thickening and calcifi cation, restricted motion and 
subvalvular disease in 41%, 25% and 34%, respectively. Carpentier IIIa leafl et dysfunction occurred in 80%. Leafl et prolapse was seen in only 20%. Patients 
older than 30 years more commonly had hypertension (69% vs. 9%, p<0.01) and HIV (32% vs. 9%, p=0.03). These fi ndings are in marked contrast to 
previous literature, in which patients were younger (mean 19 years), commonly presented with rheumatic carditis, and had no comorbidities. Leafl ets 
were pliable, with 84% having isolated leafl et prolapse, and no commissural fusion. Elongated (92%) and ruptured (25%) chordae predominated.
Conclusion: Contemporary patients with rheumatic MR are older with greater comorbidities. Acute rheumatic fever, in our setting, has become rare. 
Echocardiographic features of advanced valvular and subvalvular disease is common with very little isolated annular dilatation or leafl et prolapse. These 
fi ndings may have signifi cant implications for the management of rheumatic disease in the modern era and serve to inform strategies for future 
management of this disease.
Utility of cardiac MRI in a case of sub-aortic aneurysm 
Ruchika Meel, Richard Nethononda, Ferande Peters, Leo Mujwahuziand Mohammed R. Essop
Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
Introduction: Sub-aortic (SA) aneurysms are a rare entity of variable aetiology. Most are congenital and a result of a defect between the ventricular 
wall and valvular annuli. We report on the fi rst case of SA aneurysm imaged using cardiac MRI.
Case: A 33-year-old female, with HIV and on HAART, presented with syncope and dyspnea. Clinical examination was compatible with moderate to 
severe aortic regurgitation (AR) confi rmed by transthoracic and transesophageal echocardiograms. An eccentric jet precluded accurate assessment of 
the AR severity on echocardiography. Cardiac MRI was done to elucidate the aetiology, severity and mechanism of regurgitation. The anatomic 
relationships of the aneurysm were clearly defi ned. It confi rmed the presence of a SA aneurysm below the left coronary cusp and its retraction resulting 
in an eccentric AR jet. An assessment of moderate AR, based on regurgitant volume, was made. Furthermore, compression of the left atrium, pulmonary 
artery and RVOT was noted. No coronary artery impingement was noted.
Conclusion: CMR is a useful, non-invasive technique for comprehensive assessment of SA aneurysm.
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Focal atrial tachycardia: A retrospective review of 11 cases at Groote Schuur Hospital, an experience 
from January 2013 - July 2015
Khulile Moeketsi, Thabo Ngaka and Ashley Chin
Groote Schuur Hospital and University of Cape Town, Observatory, South Africa
Background: Focal atrial tachycardia (AT) is an uncommon cause of a supraventricular tachycardia (SVT). There is a paucity of information of AT in 
the South African population. The aim of this this study was to describe the incidence, clinical, ECG and electrophysiological characteristics of patients 
with AT.
Methods: A retrospective study was performed of consecutive patients with AT who underwent electrophysiological studies (EPS) with 3D mapping 
and radio frequency ablation (RFA) between January 2013 and July 2015 at Groote Schuur and UCT Private Academic Hospitals. 
Results: A total of 262 patients with supraventricular tachycardia underwent an EPS. Eleven (3%) patients had a diagnosis of AT. The mean age of 
patients was 43 years of which 7 patients were female (64%). All patients presented with palpitations (100%) with a mean symptom duration of 8 
months. Six (64%) patients had underlying left ventricular systolic dysfunction at presentation. Seven (100%) patients with left ventricular systolic function 
had incessant AT. Six (64%) patients had a long RP (short PR) tachycardia on ECG. The mean atrial rate of the AT was 162bpm (range: 120 - 210bpm). 
At 6 months post EPS and RFA, 8/9 (89%) had no palpitations and no recurrence of AT. There was a signifi cant recovery in left ventricular systolic 
function in 7 (100%) of the patients (tachycardia induced cardiomyopathy) at 6 months post ablation. 
Conclusion: AT is an uncommon cause of a SVT with a female preponderance. AT can cause both a long PR and short PR tachycardia. AT results in a 
tachycardia induced cardiomyopathy in a signifi cant proportion of patients. EPS and RFA has a high success rate in treating AT.
The proportion of patients in the Uganda Rheumatic Heart Disease Registry with advanced disease 
requiring urgent surgical interventions
Charles Kiiza Mondo*, Emmy Okello# and Wan Zhu Zhang#
*Mulago National Referral Hospital, Kampala, Uganda
#Uganda Heart Institute, Kampala, Uganda
Introduction: Since the establishment of the Uganda Rheumatic Heart Registry, over 900 patients have been enrolled. We sought to stratify the 
patients in the registry, according to disease severity and optimal management strategy, with a view to categorise those who need invasive intervention. 
Methods: We reviewed data of 618 patients who had enrolled in the Registry between March 2010 and February 2013. Of these, 67 patients who 
had died were excluded leaving 551 patients who were recruited. The optimum management strategy was determined according to the 2007 European 
Society of Cardiology Guidelines on the management of valvular heart disease.
Results: Out of the 551 patients’ records evaluated, 398 (72.3%) require invasive intervention, with 332 (60.3%) patients requiring surgery and 66 
(12.0%) requiring percutaneous mitral commissurotomy (PMC). This leaves only 27.7% of patients who require only medical management. Currently, 
the majority of the patients (498, 90.4%) in the registry are on medical treatment. Of the 60.3% requiring surgical intervention, only 8.0% (44 patients) 
underwent valvular surgery and 5 (1.0%) patients of the 66 (12.0%) underwent PMC successfully. 
Conclusion: There is a high proportion of patients with advanced severe RHD who require invasive treatment, yet they cannot access this therapy 
due to the high cost.
Giant right atrium due to congenital dysplastic tricuspid valve:  A report on 2 cases
Mamokgethi Moshe
Steve Biko Academic Hospital, Pretoria, South Africa
Introduction: Congenital dysplastic tricuspid valve (TV) is a rare anomaly associated with tricuspid valve insuffi ciency that usually presents with right 
heart failure in the neonatal period.
Case reports: We report on 2 cases. The fi rst patient is a 14-year-old male who presented for the fi rst time with right heart failure and atrial fi brillation. 
The 2D echocardiogram revealed a giant right atrium with spontaneous contrast, a dysplastic TV and hypoplastic right ventricle (RV). Right atrial (RA) 
tumours were excluded. The second patient is a 11-year-old male who presented at age 6 years with right heart failure. He had recurrent pericardial 
effusions that required pericardiocentesis a pericardial window. He suffered a cerebral vascular accident post cardiac tamponade. The 2D echocardiogram 
showed a giant right atrium with spontaneous contrast, dysplastic TV and hypoplastic RV. 
Discussion: Dysplastic TV encompasses a morphologic spectrum of congenital malformation of the Tricuspid valve leafl ets, chordae tendinae and 
papillary muscles that include either focal or diffuse thickening of valve leafl ets, underdevelopment of chordae tendinae and papillary muscles, incomplete 
separation of valve components from the RV wall or focal agenesis of valvular tissue. In some cases annular dilatation is more signifi cant than the 
dysplastic changes. Annular attachment of leafl ets is normal without apical displacement. 
There is functional impairment of the RV with severe TR that retards prograde fl ow through the right heart, leading to functional or anatomical RVOTO 
and RA dilatation. Differential diagnoses include: Ebstein anomaly, Uhl’s anomaly, unguarded TV orifi ce and endomyocardial fi brosis of the RV. Timing 
of presentation depends on the degree.
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Multiple large vessel aneurysms with airway obstruction:  A case of Loeys-Deitz Syndrome
Mamokgethi Moshe*, F.F. Takawira*, A. Jeevarathnum*, R. Green*, E. Honey*, E. Gous* and B. Loeys#
*Steve Biko Academic Hospital, Pretoria, South Africa
#University of Antwerpen, Antwerpen, Belgium
Introduction: Loeys-Dietz syndrome is a rare inherited connective tissue disorder (CTD) that presents with multiple aneurysmal dilatations of the 
aorta and its branches. 
Case report:  A 6-month-old girl presented with a lower respiratory tract infection in severe respiratory distress. Clinically she had subtle dysmorphism 
and a pulsatile mass in the right axilla. A chest X-ray revealed a large radio-opaque lesion occupying most of the superior mediastinum and left hemi-
thorax. A 2D echocardiogram revealed a large aneurysm of the transverse aorta with a moderate patent ductus arteriosus, massively dilated pulmonary 
arteries and no pulmonary hypertension. The CT angiography revealed multiple aneurysmal dilatations of the aorta, common carotid arteries, subclavian 
and axillary arteries. Genetic analysis revealed a heterozygous c.1460G>A (p.ARG487Gln) TGFBR1 mutation which confi rmed the diagnosis of Loeys-
Dietz syndrome. Aortic dilatation resulted in severe airway compression manifesting clinically with respiratory distress. As there was no cardiothoracic 
intervention available to treat such severe aortic dilatation and airway compression, supportive management was employed. The child demised a few 
months later, most likely from a ruptured aneurysm. 
Discussion: Loeys-Dietz syndrome is a rare autosomal dominant inherited CTD. Its exact inheritance is not known. It is caused by genetic mutations 
in the transforming growth factor beta receptor (TGFBR) 1 and 2 and TGFB2. It should be considered in patients that present with thoraco-abdominal 
aneurysms. The vascular abnormalities include: aortic root dilatation and dissection in addition to aneurysms and tortuosity throughout the arterial tree. 
It can also present with skeletal, skin and craniofacial abnormalities. Differential diagnoses include: Erhles-Danlos Syndrome, atypical Marfan Syndrome 
and familial thoracic aortic aneurysm. Management should be individualised to the needs of the patient.
Catheterisation induced Takotsubo cardiomyopathy
Bhavisha Nagar*, Antoniette Cilliers# and Gcina Dumani#
*Charlotte Maxeke Academic Hospital, Johannesburg, South Africa
#Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa
Tsakotsubo cardiomyopathy, or apical ballooning syndrome, was fi rst described in 1990 in the Japanese population. Increasing reports of the condition 
have led to it being incorporated in 2006 into the American Heart Association classifi cation of primary acquired cardiomyopathies. Interestingly, even 
though Tsakotsubo cardiomyopathy has classically been described in the literature as primarily an adult disease, it has now been identifi ed in neonates 
as young as 2 weeks old. 
Miss KM is a 21-year-old female who was diagnosed with coarctation of the aorta, ventricular septal defect and hypothyroidism at the age of 1 year. She 
has been for a subclavian fl ap, pulmonary artery banding, VSD closure and pulmonary artery debanding. Twenty years later it is noted that she has 
increasing gradient across the coarctation repair site necessitating catheterisation for percutaneous stent insertion. She developed signs of cardiac failure 
with pulmonary oedema and features of a right hemiplegia during stent insertion. Angiography of the descending aorta showed no obvious problems 
with the stent. ECG showed new onset ST changes and echocardiography revealed a ‘ballooned out ‘, myopathic apical segment of the left ventricle with 
hypercontractile basal segment, as described in Takotsubo cardiomopathy.
The recognition of this disease in the paediatric populations necessitates a closer look at what is known about this cardiomyopathy in children, as well 
as the management and predisposing factors, so that it may be correctly recognised and managed. 
Coronary cameral fi stulas 
Bhavisha Nagar* and Willy Hendson#
* Charlotte Maxeke Academic Hospital, Johannesburg, South Africa
#Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa
Coronary cameral fi stula is a rare congenital abnormality of the coronary arteries accounting for 0.2 - 0.4% of congenital cardiac abnormalities. In 
the adult population it is found in 0.08 - 0.3% of patients undergoing angiography for other reasons. It has a wide spectrum of presentation and severity. 
This is a presentation of 3 cases of coronary cameral fi stula, in an 8-day-old neonate, a 4-year-old child and a 30-year-old adult.
Case 1 is a 8-day-old neonate who presented with severe metabolic acidosis, renal failure and signs of right heart failure, together with a continuous 
murmur and displaced apex. ECG showed ST-depression and t-wave inversion in V4 and V5. Echocardiography revealed a massive left coronary cameral 
fi stula draining into the apex of the right ventricle.
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Case 2 is a 4-year-old boy who presented with gastroenteritis and the incidental fi nding of a continuous murmur with cardiomegaly on chest X-ray. 
He remained asymptomatic. There were no ischaemic changes on ECG. Angiography revealed an aneurysmal coronary cameral fi stula of the right 
coronary artery.
Case 3 is that of a 30-year-old female presenting for the fi rst time with atypical chest pain and ventricular bigemy together with a continuous murmur. 
Angiography revealed a massively dilated anomalous coronary arising off the left coronary cusp and draining into the right atrium. A normal left anterior 
descending artery and circumfl ex artery seem to arise from the aneurysm.
The management of these patients is always a topic for discussion as to whether the surgical or percutaneous route is the more favourable one, and 
the implications thereof with regards to thrombosis and embolism, and whether any management is necessary at all if the patient remains asymptomatic.
 
Holt-Oram syndrome
Nerissa Sanrisha Naidoo and Somalingum Ponnusamy
Inkosi Albert Luthuli Central Hospital, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa
Introduction: Hand-heart syndromes are genetically acquired disorders that compose  of congenital cardiac and limb deformities. We present a case 
of Holt-Oram Syndrome (HOS) with a family history that spans 3 generations.
Case presentation: A 25-year-old female, presented in preterm labour at 20 weeks.  The foetus was born without thumbs in both hands and demised 
at 3 weeks. On enquiry the patient reports a 10 year history of dizziness, palpitations and exertional dyspnoea. General examination revealed bifi d 
fi ngerised right thumb, absent left thumb, clinodactyly, bilateral hypoplastic thenar eminences, narrow sloping shoulders and pectus excavatum. 
On cardiac examination, there were features suggestive of an atrial septal defect (ASD) which was confi rmed on transthoracic echocardiogram. An 
ECG showed Atrial Flutter. Family history revealed that the patient’s mother was born with abnormal thumbs. She had 3 children with different 
partners. The index patient is the eldest child and, at birth, was found to have an absent thumb on the left hand. The second child died at seven months, 
after surgery to correct a congenital cardiac defect. The third child underwent a ventricular septal defect (VSD) closure at the age of one and also has 
skeletal abnormalities.
Discussion: HOS is a rare genetic condition. It has an autosomal-dominant mode of genetic transmission. The responsible gene has been mapped to 
12q24.1 which encodes human transcription factor TBX5.TBX5 provides instructions for making a protein that plays a role in the development of the 
heart and upper limbs. It is the mutations in this gene that lead to a wide range of phenotypes. Abnormal carpal bones are present in all cases.  There 
is usually a personal or family history of congenital heart disease (ASD or VSD). ECGs may reveal conduction abnormalities. Management will depend 
on the underlying cardiac and skeletal defect. Genetic counselling should be offered to all these patients.
Unravelling right ventricular dysfunction in isolated left ventricular non-compaction 
Samantha Nel, Ferande Peters, Elena Libhaber, Claudia Dos Santos, Hiral Matioda, Ruchika Meel, Nirthi Maharaj and 
Mohammed R. Essop
Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
Introduction: The prevalence of right ventricular (RV) dysfunction varies amongst patients with isolated left ventricular non-compaction (ILVNC) and 
has not been systematically studied in a sub-Saharan population. We aimed to (1) determine the prevalence of RV dysfunction in a sub-Saharan 
population of ILVNC patients; (2) compare the clinical and echocardiographic characteristics of ILVNC patients with RV dysfunction to those without 
RV dysfunction. 
Methods: Forty-nine patients with ILVNC, with no evidence of RV non-compaction, were enrolled in this cross-sectional study at Chris Hani 
Baragwanath Hospital, and assessed for RV dysfunction using echocardiography. RV systolic function was evaluated using the tricuspid annular peak 
systolic velocity (S’). Patients with an RV S’ <10cm/s were classifi ed as having RV systolic dysfunction.
Results: The mean age was 41.9 ± 12.0 years (43% male). The left ventricular end diastolic diameter and ejection fraction (EF) were 58.3 ± 10.3mm 
and 28.2 ± 1.5%, respectively. The pulmonary artery systolic pressure (PASP) was 41.8 ± 19.8mmHg with 39% having a PASP >35mmHg. Moderate or 
severe tricuspid regurgitation was found in 35% of cases. RV dysfunction was noted in 49% of patients. No differences were noted with regard to NYHA 
class, LVEF, LV diastolic parameters, parameters of LV remodelling, the presence of moderate/severe mitral regurgitation or pulmonary hypertension 
between patients with ILVNC, with or without RV dysfunction.
Conclusion: Almost 50% of patients with ILVNC have RV dysfunction. RV dysfunction does not appear to be related to the severity of left ventricular 
dysfunction and must therefore refl ect an intrinsic abnormality of RV contractile function.
215
Sp
rin
g 
20
15
Vo
lu
m
e 
12
 •
 N
um
be
r 4
Should immunologist be part of the heart team? A glimpse into the management of rare (likely, under 
reported) cause of acute coronary syndrome 
Pat Ntuli
Department of Medicine, Division of Cardiology, Groote Schuur Hospital and the University of Cape Town, Observatory, South Africa
Introduction:  Kounis syndrome is characterized by a group of symptoms that manifest as unstable vasospastic or non-vasospastic angina secondary 
to a hypersensitivity reaction. It was fi rst described by Nicholas Kounis and Zavras in 1991 as a concurrence of an allergic reaction with anaphylactoid 
or anaphylaxis and coronary artery spasm, or even myocardial infarction. In addition to coronary arterial involvement, the entity “Kounis syndrome” 
today encompasses other arterial systems with similar physiology, such as mesenteric and cerebral circulation, resulting in ischaemia/infarction of the 
vital organs supplied. Incidence of this condition is hard to delineate due to the number of potential instigating factors and its relatively infrequent 
documentation in literature. It remains unclear whether the reported lower rates of this condition are the direct result of remissness.
Case: We report a case of a 39-year-old man, HIV negative, with no coronary risk factors nor family history of premature coronary artery disease who 
developed, following administration of ciprofl oxacin for dysuria, severe sudden onset of retrosternal chest pain, radiating to both arm, with associated 
autonomic symptoms, in addition to the severe generalised pruritic erythematous rash and swelling of the hands, feet and oedema. An electrocardio-
gram (ECG) showed Inferior ST-Segment elevation with posterolateral extension. A diagnosis of acute coronary syndrome: Inferior STEMI with 
posterolateral extension was made and Tenecteplace, a thrombolytic therapy was administered, no resolution of symptoms, nor of ST-Segment on 
serial ECG’s. He was subsequently referred to our unit (PCI-capable center) for rescue PCI. On arrival in our institution and after meticulous history 
taking, allergic myocardial infarction… Kounis syndrome, was entertained, a blood specimen for tryptase and IgE, among other investigation was sent to 
the laboratory.  Prednisone, diphenhydramine, ranitidine and amlodipine were administered, symptoms subsided, ST-Segment elevation resolved. Cardiac 
catheterisation and coronary angiogram done within 6 hours after admission as a pharmaco-invasive strategy, showed unobstructed coronaries. 
Allergy physicians were consulted for further management.
Conclusions: There is paucity of data as to the incidence and prevalence of Kounis syndrome in this country (South Africa), rare as it is, it remains not 
infrequent. It is important to be aware of its existence. Treatment guidelines for the patients with Kounis syndrome have not been established, and most 
of the information about the treatment of this syndrome comes from individual case reports or case series. Kounis syndrome should be considered in 
young, healthy patients with no atherosclerotic risk factors when they develop acute coronary syndrome (especially inferior myocardial infarction) after 
administration of potentially allergic agent. These patients need treatment with steroids, antihistamines, fl uid resuscitation, possibly epinephrine, oxygen, 
and anti-thrombotics before transfer to the cardiac catheterisation laboratory. An allergy work-up should include the assessment of other allergies to 
food, insect stings and other environmental agents. Skin tests and food challenges may be useful in identifying the culprit agent. The intricate manage-
ment of patients with Kounis syndrome, warrants allergy physicians (Immunologists) to be remote members of the “Heart Team”.
Effi cacy and safety of liraglutide vs. sulfonylurea, both in combination with metformin during Ramadan 
in subjects with Type 2 iabetes (LIRA-Ramadan):  A randomised trial
Mahomed Omar
Private Practice, Parklands Medical Centre, Overport, Durban, South Africa
Introduction: Subjects with type 2 diabetes (T2D) who fast during Ramadan have a 5 and 7.5 fold increased risk of severe hyper- and hypoglycemia, 
respectively. The effect of liraglutide (lira) vs. sulfonylurea (SU), both + metformin (Met), on glycaemic control in subjects with T2D who fasted during 
Ramadan was examined.
Methods:  In this up to 33 week, open-label trial, adults (HbA1c 7 - 10%; BMI >20 kg/m2; stable SU + Met; intent to fast during Ramadan) were 
randomised to either switch to once daily lira 1.8mg (n=172) or continue pretrial SU (n=171), both + Met.  After 3 week dose escalation, a 6 - 9 week 
maintenance period preceded Ramadan. The primary endpoint was a change in fructosamine (FA), from start to end of Ramadan (lira n=151; 
SU n=165). 
Results:  During Ramadan, despite lower mean FA and HbA1c at start of Ramadan in the lira arm, a similar reduction in FA with lira and SU was seen 
(mean reduction 12.8umol/L and 16.4umol/L respectively). Confi rmed hypoglycemic episodes appeared to be lower with lira and fewer subjects 
withdrew during Ramadan (lira 3, SU 11). During Ramadan, lira was associated with greater weight loss [1.4kg compared to SU (0.89kg)].  AE frequencies 
appeared similar : lira 23.7%; SU 20.9%. GI AEs were more common for lira (10.5%; SU 3.7%).  A low incidence of SAEs was observed (lira 1.3%; SU 0%). 
Conclusion: During Ramadan, lira showed similar improvements in glycaemic control based on FA and HbA1c levels compared to SU with a similar 
number of AEs, apparently fewer confi rmed hypoglycemic episodes and better weight control.
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Cardiovascular magnetic resonance characterisation of myocardial involvement in tuberculous 
pericarditis with, and without, HIV co-infection 
Gregori Palkowski*, Petronella Samuels#, Sulaiman Moosa†, Mpiko Ntsekhe*, Bongani Mayosi* and Ntobeko Ntusi*
*Groote Schuur Hospital and University of Cape Town, Observatory, South Africa
#Cape Universities Body Imaging Centre, Faculty of Health Sciences, Groote Schuur Hospital and University of Cape Town, Observatory, South Africa
†Department of Radiology, 2 Military Hospital, Wynberg, Cape Town, South Africa
Background: Little is known about myocardial involvement in tuberculous pericarditis (TBP). Cardiovascular magnetic resonance (CMR) can non-
invasively assess cardiac function, myocardial oedema, infl ammation and fi brosis.
Objective: The purpose of this study was to assess cardiac and pericardial structure and function in patients with TBP, with and without HIV co-
infection, and to assess the relationship of LV function with other imaging biomarkers.
Methods: Seventy-two patients with TBP [37 male (51.3%), mean age 40 ± 14.3] were included in the study. Of these, 35 were HIV-infected [17 male 
(48.6%), mean age 34 ± 8] and 37 were HIV-uninfected [20 male (54.1%), mean age 51 ± 16]. Assessments included clinical examination, ECG, 
echocardiography, serum and pericardial biomarkers and CMR (biventricular volumes and function, oedema and late gadolinium enhancement - LGE).
Results: HIV-infected TBP patients were younger (p<0.001), had lower serum haemoglobin (p<0.001) and were more likely to have NYHA class III 
and IV symptoms (p<0.001). There were no differences on ECG and echocardiography between HIV-infected and uninfected TBP patients. There were 
also no differences in global systolic function between HIV-infected and uninfected TBP patients. Focal fi brosis on LGE was found more commonly in 
those with HIV infection (p<0.001). Pericardial effusions were frequent (>50%) in both groups of TBP patients. Determinants of LV ejection fraction in 
TBP included heart rate, LV size, E/A ratio, pericardial LGE and pericardial thickness (all p<0,01). 
Conclusions: HIV co-infection is associated with increased focal myocardial fi brosis in TBP patients, suggesting increased myocardial infl ammation in 
those with HIV co-infection. In the future, it will be important to assess the prognostic signifi cance of these fi ndings. 
Risk factors associated with acute coronary syndromes in South Africa 
Naresh Ranjith
R.K. Khan Hospital, Chatsworth, KwaZulu-Natal, South Africa
Aims: To examine the association between traditional risk factors and acute coronary syndrome (ACS) in the South Asian Indian population in 
KwaZulu-Natal, South Africa.
Methods and results: The study population comprised 4 418 patients with a mean age of 54.6 ± 10.9 years, of whom 67% were males. The majority 
presented with STEMI (75%), 16% had NSTEMI and 9% unstable angina. Visceral obesity (82%, mean waist circumference 101.43 ± 10.34cm) was the 
most commonly observed risk factor, while 78% had hypercholesterolaemia (mean 5.97 ± 1.11mmol/L) and 74% had a family history of vascular disease. 
More males compared to females were smokers (p<0.0001), while females were more likely to have visceral obesity, diabetes, hypertension, increased 
BMI and low HDL cholesterol levels (p<0.0001). Young patients (≤45 years, n=968) had a higher incidence of family history of vascular disease (83%, 
p=0.019), smoking (79%, p=<0.0001) and hypertriglyceridaemia (62%, p=0.014) compared to middle (46 - 65 years, n=2 708) or old age (>65 years, 
n=742) groups, whilst older patients were more likely to have diabetes (59%, p=0.001) and hypertension (68%, p=<0.0001).
Conclusion: Asian Indians in South African have multiple risk factors for ACS, possibly contributing to the increased incidence of coronary heart 
disease at a young age. This study further confi rms that a family history of vascular disease is strongly associated with the presence of ACS, and should 
be incorporated in future risk factor analyses.
Admission, 24 hours and discharge troponin T amongst acute myocardial infarction patients: Differing 
by prognostic contribution 
Naresh Ranjith and Sadia Patel
R.K. Khan Hospital, Chatsworth, KwaZulu-Natal, South Africa
Aims: We examined the prognostic performance of measurements of cTnT concentrations at admission, compared to discharge, in predicting major 
cardiovascular events during hospital admission and at six months follow-up. 
Methods and results: The study population comprised 1 351 patients with AMI and a mean age of 57.5 ± 11.4 years, of whom 66% were males. 
Cardiac TnT was measured on admission, 24 hours, and at discharge using the Elecsys 2010 (Roche Diagnostics). No signifi cant difference was found in 
patients who were cTnT negative at admission [n=345 (26%)] compared to the cTnT positive group [n=1 006 (74%)], with respect to baseline 
characteristics, infarct pattern, biochemical data and major cardiac events. In 475 patients (35%), serum cTnT levels were found to be higher on discharge 
from the CCU compared to admission/24 hour levels. A signifi cantly greater proportion of patients had hypertension (63% vs. 50%, p<0.001), higher 
systolic blood pressures (133, IQR 115 - 154 vs. 127, IQR 111 - 147, p<0.001), history of previous AMI (17% vs. 9%, p<0.001) and previous angina (17% 
vs. 9%, p=0.001) if the discharge cTnT levels exceeded the admission/24 hour levels. A total of 120 deaths occurred during the study period with a 
signifi cantly greater number of deaths recorded in patients whose discharge cTnT levels were higher than the admission/24 hour values [54 (11%) vs. 
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66 (8%); p=0.02, respectively]. Multivariable analysis using logistic regression showed that cardiogenic shock [OR 5.92 {95% CI 2.86 - 12.28}; p<0.001], 
cardiac failure [OR 4.80 {95% CI 2.61 - 8.82}; p<0.001], cerebrovascular accident [OR 3.95 {95% CI 1.48 - 10.58}; p=0.01], complete heart block 
[OR 3.50 {95% CI 1.22 - 10.09}; p=0.02], increasing age [OR 1.04 {95% CI 1.02 - 1.01}; p<0.001] and a greater discharge cTnT value [OR 1.61 (95% 
CI 1.01 - 2.56); p=0.04] conferred a signifi cantly higher odds of mortality. 
Conclusions: This study shows that, in addition to cardiogenic shock, cardiac failure, cerebrovascular accident, complete heart block and increasing age, 
higher cTnT level at discharge is an important independent predictor of mortality in patients with AMI, and could further improve the prognostic 
accuracy of admission values of cTnT, based on relevant patents.
Lens changes and radiation safety practices amongst paediatric cardiologists in South Africa: 
Preliminary results
Andre Rose, Lumko Ngetu, Wayne Marais and William Rae
University of the Free State, Bloemfontein, South Africa
Introduction: The eyes are one of the most radiosensitive organs. The effects of radiation on the eyes ranges from burns, keratinisation, macula 
changes and cataracts. The posterior sub-capsular lens is the most common site for cataracts and are 3.9 times more likely in interventional cardiologists. 
Radiation occupational workers are exposed to increased radiation risk in the absence of adequate radiation safety practices and with inadequate 
utilisation of personal protective equipment. Cardiologists are of the most at risk occupational categories for radiation exposure. This study was done 
to assess the understanding of paediatric cardiologists and their ability to mitigate these risks, and to determine if lens changes are seen in this 
occupational group.
Methods:  This was a cross sectional study. Data were collected at a Paediatric Cardiology workshop (Red Cross Children’s Hospital). Participants 
completed a survey and screened their eyes for lens changes. Data were analysed descriptively. Ethics clearance (ECUFS 44/2015) was obtained from 
the UFS. 
Results: The response rate was 60% (24). Three participants were excluded because they did not meet the inclusion criteria, 38% (8) were female. 
The average age was 43, 19% (4) had myopia whilst 24% (5) reported chronic eye infections. Of the participants 33% (7) reported having previously 
been screened for cataracts with no eye changes. The average number of years worked was 9.6. The average number of diagnostic procedures per week 
were 4 and the interventional procedures were 2.5 per week. Everyone used a lead apron all the time and 80% (17) used a thyroid shield all the time 
whilst 95% (20) never used lead glasses. Of the participants 33% (7) had cataract changes and 14% (3) had other eye changes.
Conclusion:  Preliminary results showed eye changes in 33% of participants. There was low compliance with the PPE utilisation. There needs to be 
greater vigilance and increased radiation safety compliance to mitigate for the risks.
Children admitted to a paediatric intensive care unit (PICU) with Fulminant Dilated 
Cardiomyopathy (DCMO) or Myocarditis in a tertiary academic hospital
Beyra Rossouw*, Andrew Argent*, Brenda Morrow* and John Lawrenson#
* Division of Critical Care and Children’s Heart Diseases, School of Child and Adolescent Health, Red Cross War Memorial Children’s Hospital, University 
of Cape Town, Rondebosch, South Africa
#Western Cape Paediatric Cardiac Services, Red Cross War Memorial Children’s Hospital, University of Cape Town, Rondebosch, South Africa 
Introduction: In South Africa curative treatment for children with DCMO/myocarditis is limited. During exacerbation these children need frequent 
readmission for supportive treatment. 
Method: A retrospective folder review describing patient characteristics, PICU treatment and outcome of children with fulminant DCMO/myocarditis 
admitted to Red Cross PICU between January 2010 and July 2015. 
Results: Ninety-fi ve children (36 males, 59 female), median age of 27.8 months were identifi ed. All presented in Ross stage 4 cardiac failure (77% in 
cardiogenic shock), with an overall median lactate of 6.5mmol/l on admission. On presentation the left ventricular ejection fraction was <30% in 79% 
and 9 developed intra-cardiac clots.  Aetiology was presumed viral myocarditis in 87% and 13% idiopathic. Adenovirus PCR was positive in 28, Parvovirus 
in 19 with multiple positive viral studies in 32.
The median number of ICU admissions per patient was 1.5 (range 1 - 5) and length of ICU stay was 14.9 days (1 - 69). Fifty-fi ve percent required 
ventilation for median of 8.1 days. Hundred percent required inotropic support for a median of 8.2 days. Eighty-two present were treated with Milrinone, 
78% on Dobutamine and 33% on Adrenaline infusions. The median maximum inotrope score was 21.9. 
Complications during ICU stay included: kidney injury in 68% with two patients needing dialysis, liver derangement in 43%, neurological events in 25% 
and 34% suffering a cardiac arrest episode. Thirty-three percent had arrhythmias of which 27% needed electrical cardioversion and 57% drug treatment 
during PICU stay. 
Sixty-three (66%) children survived to ICU discharge. The overall survival was 47%. Of the survivors, the median number of ward readmissions was 3.7 
(range 1 - 19). Total median length of ward stay was 23.2 days (1 - 138).
Of the survivors, only 22 were seen at cardiac outpatients during 2015, the rest are presumed lost to follow up.
Conclusion:  In our setting DCMO/myocarditis is associated with signifi cant duration of hospital stay, morbidity and mortality.
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Paediatric Cardiac Critical Care (PCCC) in a South African tertiary academic hospital
Beyra Rossouw*, Martie Wege*, Andrew Argent* and John Lawrenson#
* Division of Critical Care and Children’s Heart Diseases, School of Child and Adolescent Health, Red Cross War Memorial Children’s Hospital, University 
of Cape Town, Rondebosch, South Africa
#Western Cape Paediatric Cardiac Services, Red Cross War Memorial Children’s Hospital, University of Cape Town, Rondebosch, South Africa
Introduction: Knowledge is limited on PCCC in South Africa, apart from cardiac surgery reports. This study describes the patient profi les of PCCC 
admissions in a South African paediatric intensive care unit (PICU).
Method: A prospective review describing consecutive patients admitted to Red Cross PICU with a cardiac diagnosis between January 2015 and 
June 2015.
Results: Two-hundred-and-twelve PCCC patients needed 234 PICU admissions (95 males, 117 females) at median age of 33.2 months (range 1 
day - 199 months). One-hundred-and-thirty-seven admissions followed cardiac surgery, 7 elective general surgery and 90 were medical emergencies. 
Sixty-four children had a genetic diagnosis.
Indications for emergency admission included: need for respiratory support (26%), cardiogenic shock (21%), severe cyanosis (20%), decompensated 
cardiac failure (17%), post cardiac arrest (14%) and life threatening arrhythmias (2%).
The median durations of PICU stay, ventilation and inotropic infusion were 10.5, 4.8 and 4.4 days in the emergency group vs. 3.5, 1.6 and 2.3 days in the 
cardiac surgery group respectively. The median maximum inotropic score was 11 in both groups.
The fi rst diagnosis of a cardiac problem was made on this admission in 33 patients and 54 theatre procedures (24 cardiac surgical) were undertaken 
from PICU. Twenty-two patients needed 32 PICU re-admissions and 13 underwent redo cardiac operations during this study period.
Complications during PICU stay for the emergency vs. the cardiac surgery group included kidney injury in 26 vs. 11, neurological events in 19 vs. 4, 
pulmonary hypertension requiring inhaled nitric oxide in 7 vs. 10, arrhythmias requiring intervention in 12 vs. 31 and cardiac arrest episodes in 14 vs. 4 
patients. 
PCCC mortality was 5.5% vs. predicted mortality (PIM2) of 10%. Twelve of the emergency patients died in PICU vs. 1 elective cardiac surgery patient. 
Conclusion: In this centre 18% of PICU admissions are PCCC admissions. Compared to elective admissions, emergency PCCC admissions have a 
higher morbidity and mortality. 
One event leads to another: First description of Danon’s disease in South Africa 
Pieter Rossouw*, Jomien Mouton#, Paul Brink†, Althea Goosen†, Franclo Henning‡, Tertius Kohn◊ and Dan Zaharie§
*University of Stellenbosch and Tygerberg Hospital, Bellville, South Africa
#SA MRC Centre for TB Research, University of Stellenbosch and Tygerberg Hospital, Bellville, South Africa
†Division of Medicine, University of Stellenbosch and Tygerberg Hospital, Bellville, South Africa
‡Division of Neurology, University of Stellenbosch and Tygerberg Hospital, Bellville, South Africa
◊ Division for Exercise Science and Sports Medicine, Department of Human Biology, University of Cape Town, Observatory, South Africa
§  Neuropathology Unit, Division of Anatomical Pathology, Faculty of Medicine and Health Sciences, University of Stellenbosch, and Tygerberg Hospital, 
Bellville, South Africa
Introduction: The fi rst case in South Africa of Danon’s disease, a X-linked dominantly inherited disease with cardiomyopathy, myopathy, mild mental 
retardation, liver function abnormalities in males and late onset cardiomyopathy in females, is described. It is caused by a defi ciency of lysosome 
associated membrane protein 2 (LAMP-2). 
Case report and discussion: Liver function abnormalities, prior to initiating isotretinoin for acne in a 16-year-old boy, prompted referral. The 
combination found of hypertrophic cardiomyopathy and ECG evidence of pre-excitation has a limited differential diagnosis, namely, Danon’s, Fabry’s and 
Pompe’s disease, mutations in PRKAG2, some mitochondrial disorders and tuberous sclerosis. If you add mild learning disabilities and proximal muscle 
weakness and the death of his mother at age 40 with a dilated cardiomyopathy (DCM), in spite of cardiac resynchronisation therapy, Danon was most 
likely. Two siblings were unaffected. 
The probands underwent skeletal muscle biopsy, endomyocardial biopsy and analysis and screening for LAMP-2 for disease-causing mutations using 
DNA sequencing. Autophagic vacuoles with sarcolemma features (AVSFs), the latter setting it apart from acid maltase defi ciency, were seen within 
lysosomes. Furthermore, Immunohistochemical analysis showed a complete absence of LAMP-2 protein when compared with a control. DNA 
sequencing of LAMP-2 identifi ed a c.973insC frameshift mutation, affecting all amino acids downstream not present in healthy ethnically matched 
controls. The poor prognosis of Danon’s was exemplifi ed in our patient when he died, age 18, with refractory heart failure after initiation of transplant 
planning and despite accessory pathway ablation with ICD insertion. 
Recognising a unique combination of clinical symptoms, signs and events lead to the fi rst South African diagnosis of Danon’s disease. This is supported 
by histology, histochemistry and a highly plausible mutation.
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Symptoms and signs of heart failure at admission and discharge and outcomes in the sub-Saharan 
acute heart failure (THESUS-HF) registry
Mahmoud Sani*, Gad Cotter#, Beth Davison#, Bongani Mayosi†, Albertino Damasceno‡, Christopher Edwards#, Okechukwu Ogah◊, 
Charles Mondo§, Anastase DzudieΔ, Dike Ojji+, Charles Kouam KouamΔ, Ahmed Suliman**, Gerald Yonga∞, Sergine Abdou Ba∫, 
Fikru MaruΩ, Bekele AlemayehuΩ and Karen Sliwa∏
*Bayero University Kano and Aminu Kano Teaching Hospital, Kano, Nigeria 
#Momentum Research, Inc, Durham, North Carolina, United States of America
†Department of Medicine, GF Jooste and Groote Schuur Hospitals and University of Cape Town, Observatory, South Africa
‡Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique
◊Department of Medicine, University College Hospital Ibadan, Nigeria 
§Uganda Heart Institute, Kampala, Uganda
ΔDepartment of Internal Medicine, Douala General Hospital and Buea Faculty of Health Sciences, Douala, Cameroon
+Department of Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria
**Faculty of Medicine University of Khartoum, Khartoum, Sudan
∞Department of Medicine, Aga Khan University, Nairobi, Kenya
∫Service de Cardiologie, Faculte de Medecine de Dakar, Dakar, Senegal
ΩAddis Cardiac Hospital, Addis Ababa, Ethiopia
∏Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
Introduction: Symptoms and signs of heart failure (HF) are the leading reasons for admission to hospital for acute HF (AHF) and are used routinely 
throughout admission in clinical practice to assess the severity of disease and response to therapy. 
Methods: The data were collected in the THESUS-HF study, a prospective, multi-center, observational survey of AHF from 9 countries in sub-Saharan 
Africa. Patients older than 12 years diagnosed with AHF, based on symptoms and signs, were enrolled. Signs and symptoms of HF were assessed at entry 
and on days 1, 2 and 7 (or discharge if earlier) and included oxygen saturation; degree of oedema and rales; body weight and level of orthopnea. 
Changes in dyspnea and well-being relative to admission were also assessed on days 1, 2 and 7 (or discharge, if earlier). Patient determined dyspnea, as 
well as general well-being, physician determined symptoms and signs of HF as well as vital sign measurements improved throughout the admission. 
Results: After multivariable adjustment, changes in oxygen saturation and general well-being to day 7, or discharge, predicted death or HF hospitalisation 
through day 60, while baseline orthopneoa, oedema, rales and respiratory rate and changes to day 7, or discharge, in respiratory rate, oxygen saturation 
and general well-being were predictive of death through day 180.
Conclusion: In AHF patients in sub-Saharan Africa, symptoms and signs of HF improve throughout admission and repeat assessments of oxygen 
saturation and general well-being are a valuable tool in predicting outcome. 
Valvular atrial fi brillation - a common form of AF among acute heart failure patients in sub-Saharan  
Africa: Insights from THESUS-HF
Mahmoud Sani*, Gad Cotter#, Beth Davison#, Bongani Mayosi†, Albertino Damasceno‡, Christopher Edwards#, Okechukwu Ogah◊, 
Charles Mondo§, Anastase DzudieΔ, Dike Ojji+, Charles Kouam KouamΔ, Ahmed Suliman**, Gerald Yonga∞, Sergine Abdou Ba∫, 
Fikru MaruΩ, Bekele AlemayehuΩ and Karen Sliwa∏
*Bayero University Kano and Aminu Kano Teaching Hospital, Kano, Nigeria 
#Momentum Research, Inc, Durham, North Carolina, United States of America
†Department of Medicine, GF Jooste and Groote Schuur Hospitals and University of Cape Town, Observatory, South Africa
‡Faculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique
◊Department of Medicine, University College Hospital Ibadan, Nigeria 
§Uganda Heart Institute, Kampala, Uganda
ΔDepartment of Internal Medicine, Douala General Hospital and Buea Faculty of Health Sciences, Douala, Cameroon
+Department of Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria
**Faculty of Medicine University of Khartoum, Khartoum, Sudan
∞Department of Medicine, Aga Khan University, Nairobi, Kenya
∫Service de Cardiologie, Faculte de Medecine de Dakar, Dakar, Senegal
ΩAddis Cardiac Hospital, Addis Ababa, Ethiopia
∏Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa
Background: Rheumatic heart disease (RHD) is one of the leading non-communicable diseases in low- and middle-income countries and a common 
cause of heart failure in sub-Saharan Africa. Patients with RHD also suffer from complications related to atrial fi brillation (AF), infective endocarditis and 
the attendant consequences of thromboembolism. Little is known about the burden of Valvular AF among patients with acute heart failure in sub-
Saharan Africa.
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Methods: THESUS-HF was a prospective, multi-center, observational survey of AHF from 9 countries in sub-Saharan Africa. Patients older than 12 
years, diagnosed with AHF based on symptoms and signs, were enrolled. ECGs were analysed for conduction or rhythm disturbances, evidence of 
myocardial ischaemia/infarction or hypertrophy. The information obtained was entered into the database registry, together with other clinical data.
Results: Information on the presence, or absence, of AF was available for 998 (99%) of the 1 006 patients. AF was present in 184 (18.4%) of the 998 
patients. Valvular heart disease was responsible for AF in 48% of the patients with AF, second only to hypertensive heart disease with 51%. Compared 
to the patients without AF, the patients with AF are older (mean age 56.8 vs. 51.3 years) and more likely to be females (58.2% vs. 49.2%). The presence 
of AF was not associated with all cause death or readmission through 60 days, or all cause death through 180 days in the cox regression models.
Conclusions: In sub-Saharan African patients admitted for acute HF, AF is common as it is present in almost one fi fth of patients, largely of non-
ischaemic aetiology. Valvular AF causes signifi cant morbidity. This underscores the need for proper anticoagulation to prevent thromboembolism as well 
as the need for research on the role of the new oral anticoagulants (NOACs) in valvular AF.
How effective is de-endothelialisation of hearts by different concentration of deoxycholic acid in 
the rat model? 
Franziska Schlegel*, Marco Appler#, Michelle Halling*, Stefan Dhein*, Francis Edwin Smit†, Friedrich-Wilhelm Mohr* and 
Pascal Maria Dohmen#,†
*Department of Cardiac Surgery, Heart Center Leipzig, University of Leipzig, Germany
#Department of Cardiothoracic Surgery, University of the Free State, Bloemfontein, South-Africa
†Department of Cardiovascular Surgery, Charité-Universitätsmedizin Berlin, Germany
Aim: Cardiac transplantation is a well-known treatment for the end-stage of heart failure, however cardiac allograft vasculopathy (CAV) is a serious 
complication, which might lead to graft failure. This study is performed to establish a model to investigate the impact of endothelial cell function on CAV. 
Material and methods: Fourteen male Sprague Dawley rat hearts were excised and perfused with cardioplegia before attached to an Easy Cell 
Extraction System. De-endothelisation of the hearts was performed by either desoxycholic acid natrium salt (DOA) perfusion at different concentra-
tions (group 1: 1%, n=5; group 2: 0.1%, n=4; group 3: 0.01% n=5). All groups were treated for 5 minutes, extensively rinsed and perfused with Tyrode 
solution at the Langendorff system to study contractility. After fi nalising functional testing, the specimens were fi xed and embedded. Hematoxylin and 
Eosin staining (H&E) and von Willebrand factor (vWF) staining with 3’3-Diaminobenzidin (DAB) was used for quantifi ed visualisation of endothelial cells 
persistence within the coronary system at the different areas of arteries, veins and capillaries after de-endothelialisation.
Results: De-endothelialisation performed with DOA, independent on the concentration of groups 1, 2 and 3, resulted in the absence of heart 
contractility. Group 1 showed a quantitative reduction of endothelial cells by 66.9 ± 3.7%, in group 2: 47.7 ± 4.5% and in group 3: 39.3 ± 3.6%. There 
was a statistical signifi cant difference between the reduction of endothelial cells in group 1 vs. group 2 (p≤0.05) and group 1 vs. group 3 (p≤0.05). 
Histological examination showed a similar pattern within the different areas of the coronary system.
Conclusion: Further studies are needed to optimise the concentration of de-endothelialised agents to produce an endothelial cell free heart, without 
losing contractility. 
Reprogramming of bone marrow stem cells into venous endothelial cells 
Franziska Schlegel*, Marco Appler#, Michelle Halling*, Stefan Dhein*, Francis Edwin Smit†, Friedrich-Wilhelm Mohr* and 
Pascal Maria Dohmen#,†
* Department of Cardiac Surgery, Heart Center Leipzig, University of Leipzig,  Germany
#Department of Cardiothoracic Surgery, University of the Free State, Bloemfontein, South Africa
†Department of Cardiovascular Surgery, Charité-Universitätsmedizin Berlin, Germany
Objective: This study was initiated to evaluate reprogrammed bone marrow stem cells (BMSCs) into functional venous endothelial cells (VECs).
Material and methods: Pelvic bone marrow aspiration was performed in six mini-pigs to harvest BMSC using a fi lter with a 100μm cell strainer to 
determinate bone remains and tissue fragments. Bone marrow-derived mononuclear cells were isolated by sucrose gradient centrifugation, adding 
endothelial growth factor (16μg/ml) into the culture medium to transform BMSCs into VECs. BMSCs transformation and characterisation was examined 
by immunofl uorescence staining for CD 31 (PECAM) and von Willebrandt factor (vWF) staining as well as the expression of endothelial nitric oxide 
synthase (eNOS). Further NO release was examined by spectrophotometric investigation. To investigate whether transformed BMSCs could form 
angiogenetic tubes in a 3D culture, angiogenesis assay with matrigel was achieved.
Results: Reprogrammed BMSCs exhibited a typical cobblestone-like endothelial cell phenotype. Immunofl uorescence staining, including PECAM and 
vWF, showed that these differentiated BMSCs were similar to mature VECs. Furthermore, eNOS expression, by immunfl uorescence staining and western 
blot, showed no differences between BMSCs and venous and arterial ECs. Spectrophotometric examination showed comparable NO release for 
reprogrammed BMSCs (550.0 ± 115.0μmol/ml) and VEC (507.5 ± 92.5μmol/ml) under 1mmol/l ATP stimulation and at control conditions (BMSCs: 72.5 
± 47.5μmol/ml vs. VEC: 55.0 ± 3.8μmol/ml). Angiogenesis assay with matrigel indicated the tube formation of reprogrammed BMSC in vitro after 18h 
(grading 3.25) as seen in ECs. BMSCs cultured without endothelial growth factor, however were not able to develop tubes. 
Conclusion: This study showed that reprogrammed BMSCs can successfully be transformed into functional venous endothelial cells.
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Saving lost lives: The Namibian Children’s Heart Project
Fenny Shidhika*, Andre Brooks#, Susan Vosloo† and Christopher Hugo-Hamman‡
* University of Cape Town, Rondebosch, South Africa
#University of Cape Town and Christiaan Barnard Memorial Hospital, Cape Town, South Africa
†Christiaan Barnard Memorial Hospital, Cape Town, South Africa
‡ University of Cape Town and Christiaan Barnard Memorial Hospital, Cape Town, South Africa; Ministry of Health, Namibia
Introduction:  Prior to 2009, there were no cardiac services in Namibia. The aim of this project is to provide treatment for children with heart disease. 
Between September 2008 and December 2014, 148 patients seen by a single cardiologist in the Paediatric and Congenital Heart clinic at Windhoek 
Central Hospital, were referred for intervention or surgery at Christiaan Barnard Memorial Hospital. 
Objectives:  The primary aim of this study is to audit the results of this project. We describe clinical features, diagnosis, intervention or surgery, 
outcomes, complications and follow-up over 6 years and therefore, the medium term impact of this project. 
Methods:  This is a retrospective case series. Two data sources identifi ed patients. Firstly, records at Windhoek Central Hospital and secondly, hospital 
admission records at Christiaan Barnard Memorial Hospital. Case notes were reviewed for echocardiogram, cardiac catheterisation, treatment, follow-
up and outcome. 
Results:  Of 272 identifi ed as needing surgery or intervention 148 patients, aged between 3 days and 23 years, were referred to Cape Town. 
Forty-nine had diagnostic and 13 interventional catheterisations. Four patients were inoperable, either through complexity or, irreversible pulmonary 
hypertension. Cardiac surgery was performed in 112, of which 16 were palliative procedures. Complex cardiac lesions, co-morbidities and late 
presentation contribute to post-operative morbidity. There were 5 early deaths (mortality rate 4.4%). Twenty-fi ve have been lost to follow-up. 
Conclusion:  There is a heavy burden of congenital heart disease in Namibia, a low middle income country without capacity to operate on babies, 
small children and complex congenital heart disease. Opinion differs on whether countries with small populations should have independent units for 
paediatric cardiac surgery or, should refer to larger regional centers. Notwithstanding, this public-private partnership reports a large cohort of patients 
with comparatively good clinical outcome. 
Myocardial perfusion imaging using single photon emission computed tomography (SPECT) to 
differentiate ischaemic left ventricular dysfunction from dilated cardiomyopathy 
Alosha Singh*, Mohammed R. Essop* and Carlos D. Libhaber#
*Division of Cardiology, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa 
#Division of Nuclear Medicine, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa 
Background: Although dilated cardiomyopathy (DCMO) remains the most common cause for heart failure (HF) in indigent patients at this hospital, 
the incidence of ischaemic heart disease has risen signifi cantly. Differentiation of DCMO from ischaemic left ventricular dysfunction (ILVD) in patients 
presenting with HF is crucial and has important therapeutic implications, but may be diffi cult. We evaluated the utility of Technetium 99m Sestamibi 
SPECT myocardial perfusion imaging (MPI) using coronary angiography (CA) as the gold standard.
Methods: Fifty-two patients with HF with reduced ejection fraction (<40%) who had both MPI and CA were identifi ed retrospectively between 
January 2005 and December 2012. MPI scans were analysed for wall motion abnormality (WMA), reversible perfusion defects (RPD) and fi xed perfusion 
defects (FPD) and were read in a blinded manner.
Results: Thirty-three patients (63%) had ILVD and 19 (37%) had DCMO, as defi ned by CA. MPI had a sensitivity of 100% and specifi city 53% with a 
positive predictive value of 0.79. The most useful parameter on MIBI was the number of FPD. RPD and WMA were not able to reliably distinguish the 
2 groups.
Conclusion: The high sensitivity of MPI makes it a useful non-invasive screening test to differentiate DCMO from ILVD in patients presenting with HF 
and low ejection fraction, but the low specifi city means that the diagnosis requires confi rmation with CA. The most useful parameter to make this 
distinction on MPI is the number and size of FPD.
Right ventricular involvement in cardiac sarcoidosis demonstrated with cardiac magnetic resonance
Jan-Peter Smedema*, Robert-Jan van Geuns#, Gillian Ainslie†, Joris Ector‡, Hein Heidbuchel◊, Joop Schreur§ and Harry CrijnsΔ
* Netcare Blaauwberg Hospital, Milnerton, Cape Town, South Africa
#Erasmus Medical Centre, Rotterdam, The Netherlands
†Respiratory Unit, Department of Medicine, Groote Schuur Hospital, Observatory, South Africa
‡Department of Cardiology, University Hospital Gasthuisberg, Leuven, Belgium
◊University of Hasselt Heart Centre, Jessa Hospital, Hasselt, Belgium
§Department of Cardiology, Haaglanden, The Hague, The Netherlands
ΔMaastricht University Medical Centre, Maastricht, The Netherlands
Aims: Cardiac involvement in sarcoidosis is reported in up to 30% of patients. Left ventricular involvement demonstrated by contrast-enhanced cardiac 
magnetic resonance has been well validated. We sought to determine the prevalence and distribution of right ventricular late gadolinium enhancement 
in patients diagnosed with pulmonary sarcoidosis.
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Methods and results: We prospectively evaluated 86 patients diagnosed with pulmonary sarcoidosis with contrast-enhanced cardiac magnetic 
resonance for right ventricular involvement. Pulmonary artery pressures were non-invasively evaluated with Doppler echocardiography. Patient 
characteristics were compared between the groups with and without right ventricular involvement, and right ventricular enhancement was correlated 
with pulmonary hypertension, ventricular mass, volume and systolic function. Left ventricular late gadolinium enhancement was demonstrated in 28 
patients (33%). Twelve patients (14%) had right ventricular late gadolinium enhancement, with sole right ventricular enhancement in only 2 patients. The 
pattern of right ventricular consisted of free wall enhancement in 6 patients, ventricular insertion point enhancement in 6 patients and enhancement of 
the right side of the interventricular septum in 8 patients. Pulmonary arterial hypertension correlated with the presence of insertion point enhancement 
(p<0.001). Right ventricular enhancement correlated with systolic right ventricular dysfunction (p<0.001), right ventricular hypertrophy (p=0.001) and 
right ventricular dilation (p<0.001). 
Conclusion: Right ventricular enhancement was present in 14% of patients diagnosed with pulmonary sarcoidosis and 36% of patients with left 
ventricular enhancement. The presence of right ventricular enhancement correlated with pulmonary arterial hypertension, right ventricular systolic 
dysfunction, hypertrophy and dilation. 
Obese patients with hypertensive heart disease have faster atrio-ventricular conduction than 
non-obese controls
Warren Stilwaney*, Marshall Heradien#, Chris Greyling*, Bonke Khwinani#, Siyolisi Sibeko*, Rene Janse van Rensburg*, 
Warren Fransman† and Paul Brink*
* Department of Internal Medicine, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital, Bellville, South Africa
#Netcare Kuilsriver Hospital, Sonnekuil, Cape Town, South Africa
†Department of Pharmacology, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital, Bellville, South Africa
Introduction: Atrial fi brillation (AF), the most common cardiac arrhythmia, associates with increased morbidity and mortality. Left atrial remodelling, 
an important AF-substrate, typically associates with longer PR-intervals. We hypothesised that the increased sympathetic tone seen amongst obese 
hypertensive patients would shorten the PR-interval and accelerate AV conduction.
Methods: As part of a prospective epidemiological study to assess AF-risk, we screened >3 000 patients who visited a private cardiology practice for 
echocardiography, confi rmed hypertensive heart disease (HTHD) over a period of 6 years (2009 - 2015). Patients with AF, permanent pacemakers, 
signifi cant valvular heart disease, chronic renal impairment and untreated thyroid disease were excluded. Heart rate and the PR-interval were calculated 
from standard 12-lead resting ECGs. The HTHD-cohort was dichotomised into obese (BMI ≥30kg/m2) and non-obese (BMI <30kg/m2) subgroups. 
Heart rate and PR interval measurements were performed on beta-blocker (BB) naïve patients only.
Results: HTHD-prevalence was estimated at 500/3 000 (17%) and 246 of 500 (45%) included patients which were BB-naïve. When compared to non-
obese controls (n=89), obese patients (n=157) had faster resting heart rates (73.06 ± 11.85bpm vs. 70.97 ± 12.86bpm) and higher offi ce blood 
pressure (123.26/75.7mmHg vs. 118.92/73.11mmHg), suggesting increased sympathetic tone. They also had heavier left ventricles (254.06 ± 69.92grams 
vs. 240.33 ± 52.25grams) and larger left atria (41.92 ± 4.67mm vs. 39.37 ± 4.58mm, p<0.0001). Obese patients had shorter PR-intervals than non-
obese controls (166.19 ± 27ms vs. 172.09 ± 28.9ms).
Conclusion: Despite having signifi cantly larger left atria and heavier left ventricles, the PR-interval of obese subjects were not signifi cantly longer 
when compared to non-obese subjects. This association may predispose obese subjects to faster AF episodes, compared to non-obese subjects in whom 
the PR-interval lengthens as atrial size increases.
Large cardiac rhabdomyomas successfully treated with everolimus in a neonate
Farirai Fani Takawira*, Vinola Naidoo#, Nanditha Bhagwan# and Robin Kinsley†
* Division of Paediatric Cardiology, Steve Biko Acedemic Hospital and University of Pretoria, Pretoria, South Africa
#Netcare Femina Hospital, Pretoria, South Africa
†Netcare Sunninghill Hospital, Johannesburg, South Africa
Introduction: Congenital cardiac rhabdomyomas are rare and often benign. When there is no haemodynamic compromise, management is often 
conservative and the rhabdomyomas tend to regress spontaneously. When there is signifi cant chamber blood fl ow obstruction, or associated 
arrhythmias, the management is often surgical. We report on a neonate with a large rhabdomyomas and severe left ventricular outfl ow tract obstruction, 
successfully treated medically with everolimus.
Case Report: A term baby was delivered by caesarean section. He was antenatally diagnosed to have a cardiac tumour. On examination he weighed 
3.1kg and was noted to have mild respiratory distress requiring administration of oxygen by nasal cannula. He had saturations of 95%, heart rate of 
180/min and BP of 45/26 (mean=33mmHg). He had decreased peripheral perfusion. There was no cardiomegaly. A 2/6 ejection systolic murmur was 
audible in the second right inter-coastal space, radiating to the neck. There were no signs of overt congestive cardiac failure.
Echocardiography revealed multiple large intra-cardiac masses, predominantly in the left ventricular cavity. One mass obstructed the LV outfl ow tract, 
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creating severe aortic valve stenosis with very little fl ow across the AV. Due to the severe LV outfl ow tract obstruction and resultant poor perfusion he 
was started on a prostaglandin infusion. His BP and peripheral perfusion markedly improved. The respiratory distress settled and he could be weaned 
off oxygen.
Due to the high surgical risk of a debulking procedure in a 3kg neonate through the small aortic valve annulus, a conservative approach was selected to 
maintain the baby on prostaglandin infusion and a trial of medical treatment with everolimus, an inhibitor of mamalian target of rapamycin (mTOR). 
The cardiac masses were noted to gradually become smaller and the LVOT obstruction to impressively improve. The prostaglandin infusion could be 
stopped after 1 week and the everolimus stopped after 8 weeks. The LV masses had markedly reduced. There was no rebound growth of the masses 
after the everolimus was discontinued.
Discussion:  The conventional management for symptomatic cardiac rhabdomymas is surgical. This has inherent risk for morbidity and mortality in a 
young neonate with large rhabdomyomas. We report successful treatment of large, haemodynamically signifi cant cardiac rhabdomyomas using 
everolimus, a mTOR inhibitor. It has been reported to be effective against subependymal giant cell astrocytoma (SEGA) in tuberous sclerosis, renal cell 
carcinoma and neuroendocrine tumours. There have been case reports of the successful use of everolimus in the treatment of inoperable cardiac 
rhabdomyomas, which inspired its use in our patient.
 
Clinical, angiographic and procedural predictors of peri-procedural myocardial infarction during 
percutaneous coronary intervention in Johannesburg 
Nqoba Tsabedze*, Lance Mkhwanazi*, Keir McCutcheon*, Riaz Garda*, Ahmed Vachiat*, Rohan Ramjee*, Jameel Moosa*, 
Themba Maluleke*, Gloria Mukeshimana*, Saffiyyah Ebrahim Karolia#, Dineo Mpanya* and Pravin Manga*
* Faculty of Health Sciences, School of Clinical Medicine, Department of Internal Medicine, Division of Cardiology, Charlotte Maxeke Academic 
Hospital, University of the Witwatersrand, Johannesburg, South Africa
#Division of Radiology, Charlotte Maxeke Academic Hospital, Johannesburg, South Africa
Introduction:  Percutaneous coronary intervention (PCI) has been established as an effective therapy for signifi cant coronary artery disease (CAD). 
Despite medical and technological advances in coronary intervention, peri-procedural myocardial infarction (PMI) remains the most common 
complication of PCI. We prospectively investigated the frequency, predictors and clinical relevance of PMI in a tertiary academic teaching center in 
Johannesburg. 
Methods: We prospectively enrolled 153 adult patients, undergoing PCI at the Charlotte Maxeke Johannesburg Academic Hospital from 
1 February 2014 - 31 October 2014. Peri-procedural creatinine kinase-MB and hs-Troponin I were routinely measured before PCI and at 16 - 24 hours 
post-procedure. The Third Universal defi nition of myocardial infarction was used to defi ne a PMI event. Data were prospectively collected and 
retrospectively analysed by an independent research team.
Results:  One-hundred-and-fi fty-two participants met the inclusion criteria and were analysed for peri-procedural myocardial infarction. Of these 
participants 70.4% were male. The participant mean age was 58.8 + 10.9 years old and 42.1% of participants were white. Of the cases enrolled 80.3% 
presented with an acute coronary syndrome. Sixteen (10.5%) participants fulfi lled the criteria for peri-procedural myocardial infarction. Side Branch 
Pinching with preserved TIMI III fl ow was noted in 62.5% of PMI cases. Duration of procedure (p=0.007), right coronary artery intervention (p=0.042) 
and total stent length (p=0.0496) were independently associated with PMI. There was a borderline statistically signifi cant association between patients 
with peri-procedural myocardial infarction and in-patient mortality (p=0.055).
Conclusions: Peri-procedural myocardial infarction occurred in 10.5% of the cases undergoing PCI. Side-branch pinching was the most common 
risk factor. Larger studies are required in our demographic region to further defi ne relevant predictors and outcomes of peri-procedural 
myocardial infarction.
Intracoronary thrombolytic in STEMI
Ahmed Vachiat, K. McCutcheon, R. Ramjee, J. Moosa, T. Kalk, N. Tsabedze, D. Zachariah, G. Mukeshimana, T. Maluleke, 
M. Mathenjwa and P. Manga
Charlotte Maxeke Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa
Introduction: Patients in South Africa often present late with ST-segment myocardial infarction (STEMI). The culprit artery usually has a high thrombus 
burden and attempts to reperfuse the vulnerable myocardium have not been optimal with conventional methods such as thrombus aspiration.
Objectives: To assess safety and effi cacy of an intra-coronary thrombolytic regimen in younger patients presenting late with STEMI.
Methods: Over a 2 year period, 8 patients with late (>24 hours) presenting STEMI and a high thrombus burden were treated with an intra-coronary 
thrombolytic.
Results:  All 8 patients were male (4 patients were black and 4 were white). The average age was 42 years old (range 25 - 60). Two patients were given 
Streptokinase prior to repeat intra-coronary thrombolytic (Actilyse). There were no prior contra-indications for thrombolytic use. Risk factors included 
smoking and HIV (3 patients), hypertension (1 patient), family history (1 patient) and IV drug use (1 patient). No patients were diabetic and none were 
known to have dyslipidaemia or a previous myocardial infarction.
224
ABSTRACTS - SA HEART CONGRESS 2015
Coronary angiography was performed via the femoral artery. Four patients presented with anterior STEMI and 4 with inferior STEMI. Actilyse (average 
38mg) was the thrombolytic administered with routine anti-coagulation, which consisted of aspirin, clopidogrel and intravenous heparin. GPIIbIIIa 
inhibitors were not used. 
The thrombus grade prior to lytic averaged 4.6 and post lytic 0.9. Five patients were treated with medical therapy (i.e. no stent was required) and 
3 patients had a drug eluting stent inserted. One patient had a reperfusion arrhythmia. There were no bleeding complications and no deaths.
Conclusion: Intra-coronary thrombolytic appears to be a safe option with a good clinical outcome in young patients who present late (>24 hours) 
with STEMI and a high thrombus burden.
Evaluation of the SUNHEART cardiology outreach programme
J. van Deventer, A. Doubell, P. Herbst, H. Piek, C. Piek, E. Marcos and A. Pecoraro
Division of Cardiology, Department of Medicine, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital,
Bellville, South Africa
Introduction: The demand for advanced cardiac care and specialised interventions is increasing. By decentralising cardiac care and, using a hub-and-
spoke model, the SUNHEART Outreach Programme of cardiovascular care aims to improve access to advanced cardiac care in the Western Cape. 
Tygerberg Hospital is the central hub with the fi rst spoke being Paarl Hospital.
Objective: To determine the value of the SUNHEART Outreach Programme to the public health care system.
Methods: An audit of patients accessing the Outreach Programme was performed for the period May 2013 - May 2014 and compared to a historical 
cohort of patients from October 2012 - April 2013. Access to advanced cardiac care was measured by time to initial evaluation, defi nitive diagnosis or 
intervention and patient compliance with appointments. The value to the health care system was assessed by doing a cost analysis of transport of 
patients and health care workers, as well as compliance with appointments. The diagnostic accuracy and adherence to guidelines by the local health care 
providers was assessed. We documented the spectrum of disease requiring advanced cardiac care to help guide future interventions.
Results: Data of 185 patients were included. Sixty-four patients were referred to tertiary care from October 2012 - April 2013 and 121 patients were 
referred to the outreach facility from May 2013 - May 2014. There was a signifi cant reduction in waiting time with the median days to appointment of 
the historical cohort being 85 days compared to 18 days in the Outreach Programme cohort (p<0.01). Patient compliance with appointments was 
signifi cantly superior in the Outreach Programme cohort (90% vs. 56%: p<0.01). Valvular (36.5%) and ischaemic heart disease (35.5%) were the major 
pathologies. Transport costs per patient treated was signifi cantly reduced in the outreach programme cohort (R118.09 vs. R308.77).
Conclusion: Decentralisation of services, in the form of an Outreach Programme with a central hub, improves access to advanced cardiac care by 
decreasing waiting time, improving compliance with appointments and decreasing travel costs. 
Tri-leafl et mitral valves - when lighting strikes thrice 
Annari van Rensburg, Philip Herbst, Charles Kyriakakis, Alfonso Pecoraro and Anton Doubell
Division of Cardiology, Department of Medicine, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital,
Bellville, South Africa
A tri-leafl et mitral valve is a novel echocardiographic fi nding that has only been described in 2 case reports. We report on 3 patients recently found to 
have tri-leafl et mitral valves in the setting of atrioventricular concordance. 
The fi rst patient is a 22-year-old male referred to our congenital heart disease clinic for follow-up of a restrictive VSD. Echocardiography revealed a 
quadricuspid aortic valve and an unusual appearance of the mitral valve. There were 3, evenly spaced commissures with central coaptation, present as 
well as 3 papillary muscles – a medial, a small or rudimentary antero-lateral and a posteriorly positioned papillary muscle. Despite these morphological 
abnormalities, only trace regurgitation was detected. 3D echocardiography allowed for a more detailed morphological and functional assessment. 
The second patient is a 49-year-old male evaluated for chronic severe mitral regurgitation. Echocardiography confi rmed a dilated left ventricle with 
severe mitral regurgitation with a tri-leafl et mitral valve, also with 3 (medial, lateral and posterior) papillary muscles present. No other structural 
abnormalities were present. 
The third patient is a 50-year-old male evaluated for chronic severe mitral regurgitation. Initially this was assessed as being due to prolapse, but more 
careful scrutiny confi rmed a dilated left ventricle with severe mitral regurgitation with a tri-leafl et mitral valve with 3 papillary muscles present: a 
rudimentary basal medial PM, an anterolateral PM and a more apical posterior PM. 3D echocardiography clearly shows the 3 commissures. 
The mitral valves of all 3 patients mimic the normal tricuspid valve morphology with 3 leafl ets, 3 commissures, 3 papillary muscles (of which one is small/
rudimentary) and cords from each papillary muscle (including from the rudimentary papillary muscle) to 2 separate leafl ets.
The tri-leafl et mitral valve is a rare congenital abnormality that is increasingly being recognised with advances in imaging techniques. 
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Critical review of paediatric and congenital cardiac transplantation at Christiaan Barnard Memorial 
Hospital since 1995
Susan Vosloo and Mareli Coetzer
Christiaan Barnard Memorial Hospital, Cape Town, South Africa
Introduction: Cardiac transplantation commenced in 1995.  
Methods: Referrals for transplant evaluation for end-stage cardiac failure in patients <20 years of age, and with congenital defects not suitable for 
conventional repair regardless of age, were analysed.
A comparison was made between two 10 year periods (A: 1995 - 2004 and B: 2005 - 2014) as well as between the fi rst (C: 1995 - 1999) and last 5 
year period (D: 2010 - 2014), of: (a) transplants done, and (b) deaths on the waiting list.
Results: Fifty-nine patients were referred for transplant evaluation (A=30; B=29). Of those, 48 (A=24; B=24) were wait-listed.  
Transplants were done in 25 patients (A=16/24; B= 10/24), a reduction of 36% comparing the 2 periods. Comparing the fi rst and last 5 year periods 
(C and D), the reduction was more pronounced with 12/13 transplanted in C, and only 2/10 in D, a reduction from 92.3 to 20%.
SA annual numbers of thoracic transplants were compared to the trend observed in this study. Period A, when compared to B, showed a 34.4% 
reduction in numbers and for period C to D it decreased by 38%.  
Deaths on the waiting list occurred in 22/48 patients (A=7/24; B=15/24), more than doubling from 29 - 62%.  Whilst 1 of 13 patients suitable for 
transplantation died while waiting during the fi rst  5 years (C), the mortality was 8 out of 10 (80%) during the last 5 years (D).
Of those, 17 patients died within 3 months awaiting organs (A=6; B=11) and 5 died after >3 months (A=1; B=4).
Conclusions: (1) Numbers of paediatric and congenital cardiac transplants decreased more than comparative SA statistics. (2) Mortality of patients 
on the waiting list increased markedly over time with most deaths (77.2%) within the fi rst 3 months on the waiting list.
SHARE-TAVI registry
Hellmuth Weich*, Jacques Scherman#, Elizabeth Schaafsma† and Mpiko Ntsekhe‡
On behalf of the SHARE-TAVI Registry investigators
* Division of Cardiology, Department of Medicine, Faculty of Medicine and Health Sciences, University of Stellenbosch and Tygerberg Hospital, 
Bellville, South Africa
#Division of Cardiothoracic Surgery, Groote Schuur Hospital and University of Cape Town, Observatory, South Africa
†SA Heart Association, Tygerberg Hospital, South Africa
‡ Division of Cardiology, Groote Schuur Hospital and University of Cape Town, Observatory, South Africa
Background: The SHARE-TAVI registry was set up to gather data on all the TAVI implants in South Africa with the primary aim of improving patient 
care in the long term. Data capture started in November 2014 and this presentation aims to provide the fi rst feedback of the data. An outline of 
the capture system will be discussed.
Results:  A total of 76 patients were entered into the system from 14 different teams, of which 8 are actively capturing data. Data for implants in 
non-aortic position was not collected and it is important to note that this data does not include all cases screened for TAVI.  Of the 76 cases entered, 
68 were approved by the Heart team for TAVIs, and 45 received implants. Reasons for not proceeding to implant included funding refusal (2), death 
(3), patient declined procedure (1) and anatomy not suitable or valve severity moderate (2). Risk profi le: average age was 80 years and mean EuroSCORE 
(Log.) was 19.12, mean EuroSCORE 2 was 7.684 and mean STS score was 7.408.  Of the 62% of patients who had frank contra-indications to 
conventional surgery, other risks included frailty (n=29), porcelain aorta (n=8), patent LIMA graft (n=10) and hostile thorax in 5 patients.
Procedural success was 93.3%, the remainder experienced either device/delivery malfunction (n=1) or residual aortic regurgitation (n=2) and 
complications are discussed. Access route was TF (50%), TA in 5.4% and not recorded in the remainder. Hospital stay was a mean stay in ICU of 
2.28 days, high care 1.23 days and ward stay of 3.09 days. Follow up 30 day data is complete for 42% and 30-day mortality was 4.4% in patients 
undergoing TAVI.
